Financial Metrics
NTRA Natera, Inc.Financial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 61902000.0 | — | USD | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 51984000.0 | -16.0% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 53889000.0 | +3.7% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 46901000.0 | -13.0% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 52283000.0 | +11.5% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 55910000.0 | +6.9% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 62340000.0 | +11.5% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 63069000.0 | +1.2% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | 65280000.0 | +3.5% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 66824000.0 | +2.4% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | 74355000.0 | +11.3% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | 77909000.0 | +4.8% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 94012000.0 | +20.7% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | 86472000.0 | -8.0% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 98143000.0 | +13.5% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 152316000.0 | +55.2% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 142026000.0 | -6.8% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 158116000.0 | +11.3% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 194133000.0 | +22.8% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 198200000.0 | +2.1% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 210637000.0 | +6.3% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 241756000.0 | +14.8% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 261404000.0 | +8.1% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 268306000.0 | +2.6% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 367741000.0 | +37.1% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 413351000.0 | +12.4% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 439758000.0 | +6.4% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 501830000.0 | +14.1% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 546600000.0 | +8.9% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 592183000.0 | +8.3% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 212512000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 209625000.0 | -1.4% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | 257654000.0 | +22.9% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | 302328000.0 | +17.3% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | 391005000.0 | +29.3% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | 625486000.0 | +60.0% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 820222000.0 | +31.1% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 1082571000.0 | +32.0% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 1696911000.0 | +56.7% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 2306113000.0 | +35.9% | USD | 10-K | 2026-02-27 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2024-09-30 | 723520000.0 | — | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 11299000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 15325000.0 | +35.6% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 24176000.0 | +57.8% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 38778000.0 | +60.4% | USD | 10-K | 2020-03-02 |
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -9605000.0 | — | USD | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -22515000.0 | -134.4% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -26655000.0 | -18.4% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -34550000.0 | -29.6% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -28371000.0 | +17.9% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -25789000.0 | +9.1% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -30517000.0 | -18.3% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -27218000.0 | +10.8% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -27166000.0 | +0.2% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -31746000.0 | -16.9% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -28636000.0 | +9.8% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -21094000.0 | +26.3% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -34872000.0 | -65.3% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -51660000.0 | -48.1% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -55777000.0 | -8.0% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -63017000.0 | -13.0% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -115294000.0 | -83.0% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -150197000.0 | -30.3% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -137130000.0 | +8.7% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -143085000.0 | -4.3% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -119052000.0 | +16.8% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -138301000.0 | -16.2% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -112426000.0 | +18.7% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -110982000.0 | +1.3% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -74314000.0 | +33.0% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -43902000.0 | +40.9% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -39338000.0 | +10.4% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -79177000.0 | -101.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -110372000.0 | -39.4% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -97576000.0 | +11.6% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -101050000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -135341000.0 | -33.9% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -114628000.0 | +15.3% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -116287000.0 | -1.4% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -216277000.0 | -86.0% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -468174000.0 | -116.5% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -541040000.0 | -15.6% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -446245000.0 | +17.5% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -222294000.0 | +50.2% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -309911000.0 | -39.4% | USD | 10-K | 2026-02-27 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -8685000.0 | — | USD | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -31841000.0 | -266.6% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -57858000.0 | -81.7% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -33480000.0 | +42.1% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -62546000.0 | -86.8% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -90411000.0 | -44.6% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -32873000.0 | +63.6% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -66697000.0 | -102.9% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -96313000.0 | -44.4% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -34091000.0 | +64.6% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -66507000.0 | -95.1% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -89644000.0 | -34.8% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -35372000.0 | +60.5% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -95009000.0 | -168.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -153331000.0 | -61.4% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -63853000.0 | +58.4% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -179879000.0 | -181.7% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -331152000.0 | -84.1% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -138595000.0 | +58.1% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -283746000.0 | -104.7% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -405226000.0 | -42.8% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -136937000.0 | +66.2% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -247740000.0 | -80.9% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -356770000.0 | -44.0% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -67599000.0 | +81.1% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -105063000.0 | -55.4% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -136655000.0 | -30.1% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -66936000.0 | +51.0% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -167874000.0 | -150.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -255418000.0 | -52.1% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -100327000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -137628000.0 | -37.2% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -128154000.0 | +6.9% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -124827000.0 | +2.6% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -229743000.0 | -84.0% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -471716000.0 | -105.3% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -547799000.0 | -16.1% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -434801000.0 | +20.6% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -190426000.0 | +56.2% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -208160000.0 | -9.3% | USD | 10-K | 2026-02-27 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.17 | — | USD/shares | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -0.46 | -170.6% | USD/shares | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -0.5 | -8.7% | USD/shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -0.63 | -26.0% | USD/shares | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -0.55 | +12.7% | USD/shares | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -0.52 | +5.5% | USD/shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -0.61 | -17.3% | USD/shares | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -0.62 | -1.6% | USD/shares | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -0.49 | +21.0% | USD/shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -0.54 | -10.2% | USD/shares | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | -0.48 | +11.1% | USD/shares | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | -0.33 | +31.2% | USD/shares | 10-Q | 2019-11-08 |
| Quarterly | 2021-03-31 | -0.74 | -124.2% | USD/shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -1.32 | -78.4% | USD/shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -1.63 | -23.5% | USD/shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -1.45 | +11.0% | USD/shares | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -1.5 | -3.4% | USD/shares | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -1.25 | +16.7% | USD/shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -1.23 | +1.6% | USD/shares | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -0.97 | +21.1% | USD/shares | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -0.95 | +2.1% | USD/shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -0.56 | +41.1% | USD/shares | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -0.3 | +46.4% | USD/shares | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -0.26 | +13.3% | USD/shares | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -0.5 | -92.3% | USD/shares | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -0.74 | -48.0% | USD/shares | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -0.64 | +13.5% | USD/shares | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -1.95 | — | USD/shares | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -2.58 | -32.3% | USD/shares | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -0.51 | +80.2% | USD/shares | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | -1.79 | -251.0% | USD/shares | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -2.84 | -58.7% | USD/shares | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -5.21 | -83.5% | USD/shares | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -5.57 | -6.9% | USD/shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -3.78 | +32.1% | USD/shares | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -1.53 | +59.5% | USD/shares | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -1.52 | +0.7% | USD/shares | 10-K | 2026-02-27 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.17 | — | USD/shares | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -0.46 | -170.6% | USD/shares | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -0.5 | -8.7% | USD/shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -0.65 | -30.0% | USD/shares | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -0.55 | +15.4% | USD/shares | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -0.52 | +5.5% | USD/shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -0.61 | -17.3% | USD/shares | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -0.62 | -1.6% | USD/shares | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -0.49 | +21.0% | USD/shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -0.54 | -10.2% | USD/shares | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | -0.48 | +11.1% | USD/shares | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | -0.33 | +31.2% | USD/shares | 10-Q | 2019-11-08 |
| Quarterly | 2021-03-31 | -0.74 | -124.2% | USD/shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -1.32 | -78.4% | USD/shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -1.63 | -23.5% | USD/shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -1.45 | +11.0% | USD/shares | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -1.5 | -3.4% | USD/shares | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -1.25 | +16.7% | USD/shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -1.23 | +1.6% | USD/shares | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -0.97 | +21.1% | USD/shares | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -0.95 | +2.1% | USD/shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -0.56 | +41.1% | USD/shares | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -0.3 | +46.4% | USD/shares | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -0.26 | +13.3% | USD/shares | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -0.5 | -92.3% | USD/shares | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -0.74 | -48.0% | USD/shares | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -0.64 | +13.5% | USD/shares | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -1.95 | — | USD/shares | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -2.59 | -32.8% | USD/shares | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -0.51 | +80.3% | USD/shares | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | -1.79 | -251.0% | USD/shares | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -2.84 | -58.7% | USD/shares | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -5.21 | -83.5% | USD/shares | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -5.57 | -6.9% | USD/shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -3.78 | +32.1% | USD/shares | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -1.53 | +59.5% | USD/shares | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -1.52 | +0.7% | USD/shares | 10-K | 2026-02-27 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 33985000.0 | — | USD | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 16557000.0 | -51.3% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 25322000.0 | +52.9% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2016-12-31 | 15256000.0 | -39.8% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2017-03-31 | 9086000.0 | -40.4% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 7138000.0 | -21.4% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 11211000.0 | +57.1% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2017-12-31 | 12620000.0 | +12.6% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 33674000.0 | +166.8% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 12306000.0 | -63.5% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 34535000.0 | +180.6% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 46407000.0 | +34.4% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 34281000.0 | -26.1% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 29928000.0 | -12.7% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 51609000.0 | +72.4% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 61926000.0 | +20.0% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 74144000.0 | +19.7% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 77322000.0 | +4.3% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 209351000.0 | +170.8% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 48668000.0 | -76.8% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 65126000.0 | +33.8% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 62811000.0 | -3.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 95103000.0 | +51.4% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 84386000.0 | -11.3% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 158298000.0 | +87.6% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 91298000.0 | -42.3% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 57042000.0 | -37.5% | USD | 10-Q | 2022-11-09 |
| Annual | 2016-12-31 | 15256000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 12620000.0 | -17.3% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 46407000.0 | +267.7% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 61926000.0 | +33.4% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 48668000.0 | -21.4% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 84386000.0 | +73.4% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 466005000.0 | +452.2% | USD | 10-K | 2023-03-01 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 6105000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 6171000.0 | +1.1% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 9408000.0 | +52.5% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 13396000.0 | +42.4% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 7478000.0 | -44.2% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 7107000.0 | -5.0% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 7342000.0 | +3.3% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 44089000.0 | +500.5% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 50326000.0 | +14.1% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 57002000.0 | +13.3% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 60397000.0 | +6.0% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 62223000.0 | +3.0% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 60293000.0 | -3.1% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 62974000.0 | +4.4% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 58905000.0 | -6.5% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 53351000.0 | -9.4% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 61577000.0 | +15.4% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 58706000.0 | -4.7% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 70674000.0 | +20.4% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 78565000.0 | +11.2% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 87562000.0 | +11.5% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 100130000.0 | +14.4% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 110416000.0 | +10.3% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 122074000.0 | +10.6% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 167862000.0 | +37.5% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 208312000.0 | +24.1% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 236362000.0 | +13.5% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 244385000.0 | +3.4% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 246785000.0 | +1.0% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 260065000.0 | +5.4% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 255147000.0 | -1.9% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 278289000.0 | +9.1% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 288748000.0 | +3.8% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 335936000.0 | +16.3% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 306876000.0 | -8.7% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 314165000.0 | +2.4% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 318233000.0 | +1.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 309224000.0 | -2.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 286379000.0 | -7.4% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 13396000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 44089000.0 | +229.1% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 62223000.0 | +41.1% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 53351000.0 | -14.3% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 78565000.0 | +47.3% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 122074000.0 | +55.4% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 244385000.0 | +100.2% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 278289000.0 | +13.9% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 314165000.0 | +12.9% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 296528000.0 | -5.6% | USD | 10-K | 2026-02-27 |
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 6689000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 8893000.0 | +32.9% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 9249000.0 | +4.0% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 6414000.0 | -30.7% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 8223000.0 | +28.2% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 7359000.0 | -10.5% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 9188000.0 | +24.9% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 8998000.0 | -2.1% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 11911000.0 | +32.4% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 12324000.0 | +3.5% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 12244000.0 | -0.6% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 13633000.0 | +11.3% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 13748000.0 | +0.8% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 15236000.0 | +10.8% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 12514000.0 | -17.9% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 12394000.0 | -1.0% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 14161000.0 | +14.3% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 18033000.0 | +27.3% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 20377000.0 | +13.0% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 20031000.0 | -1.7% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 23676000.0 | +18.2% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 28409000.0 | +20.0% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 28022000.0 | -1.4% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 26909000.0 | -4.0% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 25048000.0 | -6.9% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 30465000.0 | +21.6% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 40428000.0 | +32.7% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 35406000.0 | -12.4% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 40683000.0 | +14.9% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 42688000.0 | +4.9% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 42076000.0 | -1.4% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 40759000.0 | -3.1% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 43024000.0 | +5.6% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 40985000.0 | -4.7% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 48724000.0 | +18.9% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 44744000.0 | -8.2% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 50367000.0 | +12.6% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 54272000.0 | +7.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 64644000.0 | +19.1% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 6414000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 8998000.0 | +40.3% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 13633000.0 | +51.5% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 12394000.0 | -9.1% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 20031000.0 | +61.6% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 26909000.0 | +34.3% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 35406000.0 | +31.6% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 40759000.0 | +15.1% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 44744000.0 | +9.8% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 68443000.0 | +53.0% | USD | 10-K | 2026-02-27 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 248625000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 237175000.0 | -4.6% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 212278000.0 | -10.5% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 174115000.0 | -18.0% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 140161000.0 | -19.5% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 123104000.0 | -12.2% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 169240000.0 | +37.5% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 180625000.0 | +6.7% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 187523000.0 | +3.8% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 165370000.0 | -11.8% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 248688000.0 | +50.4% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 240518000.0 | -3.3% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 208081000.0 | -13.5% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 321967000.0 | +54.7% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 323737000.0 | +0.5% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 523167000.0 | +61.6% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 497208000.0 | -5.0% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 663504000.0 | +33.4% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 916012000.0 | +38.1% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 862663000.0 | -5.8% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 791403000.0 | -8.3% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 739888000.0 | -6.5% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 1191223000.0 | +61.0% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 1093138000.0 | -8.2% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 980226000.0 | -10.3% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 901555000.0 | -8.0% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 829629000.0 | -8.0% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 1211817000.0 | +46.1% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 1129468000.0 | -6.8% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 1065512000.0 | -5.7% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 1267276000.0 | +18.9% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 1258549000.0 | -0.7% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 1261444000.0 | +0.2% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 1301816000.0 | +3.2% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 1322565000.0 | +1.6% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 1375820000.0 | +4.0% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 1416385000.0 | +2.9% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 1431596000.0 | +1.1% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 1447323000.0 | +1.1% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 174115000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 180625000.0 | +3.7% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 240518000.0 | +33.2% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 523167000.0 | +117.5% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 862663000.0 | +64.9% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 1093138000.0 | +26.7% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 1211817000.0 | +10.9% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 1258549000.0 | +3.9% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 1375820000.0 | +9.3% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 1496939000.0 | +8.8% | USD | 10-K | 2026-02-27 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 265748000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 261267000.0 | -1.7% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 242385000.0 | -7.2% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 210680000.0 | -13.1% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 176024000.0 | -16.4% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 158425000.0 | -10.0% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 204056000.0 | +28.8% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 214613000.0 | +5.2% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 218655000.0 | +1.9% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 194361000.0 | -11.1% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 277309000.0 | +42.7% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 268171000.0 | -3.3% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 261445000.0 | -2.5% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 383326000.0 | +46.6% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 380250000.0 | -0.8% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 582656000.0 | +53.2% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 558639000.0 | -4.1% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 723261000.0 | +29.5% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 976713000.0 | +35.0% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 932153000.0 | -4.6% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 893512000.0 | -4.1% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 849956000.0 | -4.9% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 1311374000.0 | +54.3% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 1236487000.0 | -5.7% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 1144664000.0 | -7.4% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 1066976000.0 | -6.8% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 1009112000.0 | -5.4% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 1394474000.0 | +38.2% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 1318880000.0 | -5.4% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 1247893000.0 | -5.4% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 1446520000.0 | +15.9% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 1441699000.0 | -0.3% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 1468205000.0 | +1.8% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 1516989000.0 | +3.3% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 1590947000.0 | +4.9% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 1660735000.0 | +4.4% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 1732366000.0 | +4.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 1757066000.0 | +1.4% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 1821482000.0 | +3.7% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 210680000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 214613000.0 | +1.9% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 268171000.0 | +25.0% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 582656000.0 | +117.3% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 932153000.0 | +60.0% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 1236487000.0 | +32.6% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 1394474000.0 | +12.8% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 1441699000.0 | +3.4% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 1660735000.0 | +15.2% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 2398344000.0 | +44.4% | USD | 10-K | 2026-02-27 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 84153000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 95488000.0 | +13.5% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 95979000.0 | +0.5% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 96415000.0 | +0.5% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 93015000.0 | -3.5% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 98270000.0 | +5.6% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 91530000.0 | -6.9% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 105561000.0 | +15.3% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 104383000.0 | -1.1% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 98130000.0 | -6.0% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 101829000.0 | +3.8% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 113981000.0 | +11.9% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 112656000.0 | -1.2% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 126925000.0 | +12.7% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 137974000.0 | +8.7% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 179874000.0 | +30.4% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 176642000.0 | -1.8% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 175560000.0 | -0.6% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 195872000.0 | +11.6% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 199053000.0 | +1.6% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 166969000.0 | -16.1% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 197988000.0 | +18.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 199714000.0 | +0.9% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 218956000.0 | +9.6% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 231072000.0 | +5.5% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 251618000.0 | +8.9% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 267281000.0 | +6.2% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 310499000.0 | +16.2% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 290969000.0 | -6.3% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 276856000.0 | -4.9% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 289923000.0 | +4.7% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 307274000.0 | +6.0% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 305949000.0 | -0.4% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 314574000.0 | +2.8% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 301416000.0 | -4.2% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 344045000.0 | +14.1% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 365677000.0 | +6.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 384836000.0 | +5.2% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 442016000.0 | +14.9% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 96415000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 105561000.0 | +9.5% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 113981000.0 | +8.0% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 179874000.0 | +57.8% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 199053000.0 | +10.7% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 218956000.0 | +10.0% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 310499000.0 | +41.8% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 307274000.0 | -1.0% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 344045000.0 | +12.0% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 441228000.0 | +28.2% | USD | 10-K | 2026-02-27 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 84153000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 97452000.0 | +15.8% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 102071000.0 | +4.7% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 104204000.0 | +2.1% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 102352000.0 | -1.8% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 107517000.0 | +5.0% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 173872000.0 | +61.7% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 189196000.0 | +8.8% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 222531000.0 | +17.6% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 216398000.0 | -2.8% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 220738000.0 | +2.0% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 236009000.0 | +6.9% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 256459000.0 | +8.7% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 290238000.0 | +13.2% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 295556000.0 | +1.8% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 303945000.0 | +2.8% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 299712000.0 | -1.4% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 418994000.0 | +39.8% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 440713000.0 | +5.2% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 445917000.0 | +1.2% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 521067000.0 | +16.9% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 550846000.0 | +5.7% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 552357000.0 | +0.3% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 583183000.0 | +5.6% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 602329000.0 | +3.3% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 622394000.0 | +3.3% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 647491000.0 | +4.0% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 688730000.0 | +6.4% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 668307000.0 | -3.0% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 651746000.0 | -2.5% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 661862000.0 | +1.6% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 676372000.0 | +2.2% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 674094000.0 | -0.3% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 680469000.0 | +0.9% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 712422000.0 | +4.7% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 465315000.0 | -34.7% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 492691000.0 | +5.9% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 510884000.0 | +3.7% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 569294000.0 | +11.4% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 104204000.0 | — | USD | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 189196000.0 | +81.6% | USD | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 236009000.0 | +24.7% | USD | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 303945000.0 | +28.8% | USD | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 445917000.0 | +46.7% | USD | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 583183000.0 | +30.8% | USD | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 688730000.0 | +18.1% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 676372000.0 | -1.8% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 465315000.0 | -31.2% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 685931000.0 | +47.4% | USD | 10-K | 2026-02-27 |
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 181595000.0 | — | USD | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 163815000.0 | -9.8% | USD | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 140314000.0 | -14.3% | USD | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 106476000.0 | -24.1% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 73672000.0 | -30.8% | USD | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 50908000.0 | -30.9% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 30184000.0 | -40.7% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 25417000.0 | -15.8% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2018-03-31 | -3876000.0 | -115.2% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-06-30 | -22037000.0 | -468.6% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2018-09-30 | 56571000.0 | +356.7% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2018-12-31 | 32162000.0 | -43.1% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2019-03-31 | 4986000.0 | -84.5% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-06-30 | 93088000.0 | +1767.0% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2019-09-30 | 84694000.0 | -9.0% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2019-12-31 | 278711000.0 | +229.1% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2020-03-31 | 258927000.0 | -7.1% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-06-30 | 304267000.0 | +17.5% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2020-09-30 | 536000000.0 | +76.2% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2020-12-31 | 486236000.0 | -9.3% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2021-03-31 | 372445000.0 | -23.4% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-06-30 | 299110000.0 | -19.7% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2021-09-30 | 759017000.0 | +153.8% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2021-12-31 | 653304000.0 | -13.9% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2022-03-31 | 542335000.0 | -17.0% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-06-30 | 444582000.0 | -18.0% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2022-09-30 | 361621000.0 | -18.7% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2022-12-31 | 705744000.0 | +95.2% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2023-03-31 | 650573000.0 | -7.8% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-06-30 | 596147000.0 | -8.4% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2023-09-30 | 784658000.0 | +31.6% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2023-12-31 | 765327000.0 | -2.5% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2024-03-31 | 794111000.0 | +3.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-06-30 | 836520000.0 | +5.3% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2024-09-30 | 878525000.0 | +5.0% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2024-12-31 | 1195420000.0 | +36.1% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 1239675000.0 | +3.7% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-06-30 | 1246182000.0 | +0.5% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-09-30 | 1252188000.0 | +0.5% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 143577000.0 | — | USD | 10-K | 2020-03-02 |
| Annual | 2017-12-31 | 25417000.0 | -82.3% | USD | 10-K | 2021-02-26 |
| Annual | 2018-12-31 | 32162000.0 | +26.5% | USD | 10-K | 2022-02-25 |
| Annual | 2019-12-31 | 278711000.0 | +766.6% | USD | 10-K | 2023-03-01 |
| Annual | 2020-12-31 | 486236000.0 | +74.5% | USD | 10-K | 2024-02-29 |
| Annual | 2021-12-31 | 653304000.0 | +34.4% | USD | 10-K | 2025-02-28 |
| Annual | 2022-12-31 | 705744000.0 | +8.0% | USD | 10-K | 2026-02-27 |
| Annual | 2023-12-31 | 765327000.0 | +8.4% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 1195420000.0 | +56.2% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 1712413000.0 | +43.2% | USD | 10-K | 2026-02-27 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2021-12-31 | 280394000.0 | — | USD | 10-K | 2022-02-25 |
| Annual | 2022-12-31 | 281653000.0 | +0.4% | USD | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 282945000.0 | +0.5% | USD | 10-K | 2025-02-28 |
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-06-30 | -20190000.0 | — | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -44406000.0 | -119.9% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -24620000.0 | +44.6% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -38394000.0 | -55.9% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -69696000.0 | -81.5% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 1046000.0 | +101.5% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -34497000.0 | -3398.0% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -57768000.0 | -67.5% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -31819000.0 | +44.9% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -35751000.0 | -12.4% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -48390000.0 | -35.4% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -35100000.0 | +27.5% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -76080000.0 | -116.8% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -109210000.0 | -43.5% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -74876000.0 | +31.4% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -145439000.0 | -94.2% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -236500000.0 | -62.6% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -137277000.0 | +42.0% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -248126000.0 | -80.7% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -350374000.0 | -41.2% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -81108000.0 | +76.9% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -159651000.0 | -96.8% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -189350000.0 | -18.6% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 27001000.0 | +114.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 30991000.0 | +14.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 82777000.0 | +167.1% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 44452000.0 | -46.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 82026000.0 | +84.5% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 141413000.0 | +72.4% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -74052000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -97825000.0 | -32.1% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -70581000.0 | +27.8% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -63444000.0 | +10.1% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -182512000.0 | -187.7% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -335236000.0 | -83.7% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -431501000.0 | -28.7% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -246955000.0 | +42.8% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 135664000.0 | +154.9% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 215301000.0 | +58.7% | USD | 10-K | 2026-02-27 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-06-30 | -2438000.0 | — | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 30089000.0 | +1334.2% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 17720000.0 | -41.1% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 27506000.0 | +55.2% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -13733000.0 | -149.9% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 25059000.0 | +282.5% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 33684000.0 | +34.4% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -26849000.0 | -179.7% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 12917000.0 | +148.1% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -100995000.0 | -881.9% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -71108000.0 | +29.6% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 43492000.0 | +161.2% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -121954000.0 | -380.4% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -232295000.0 | -90.5% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 86740000.0 | +137.3% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 146709000.0 | +69.1% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -284697000.0 | -294.1% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 207033000.0 | +172.7% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 241822000.0 | +16.8% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 308421000.0 | +27.5% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 15870000.0 | -94.9% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 63060000.0 | +297.4% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 144353000.0 | +128.9% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 138255000.0 | -4.2% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 106202000.0 | -23.2% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 148742000.0 | +40.1% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -16815000.0 | -111.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -40712000.0 | -142.1% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -60617000.0 | -48.9% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 47027000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 13784000.0 | -70.7% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -5161000.0 | -137.4% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -266353000.0 | -5060.9% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -331461000.0 | -24.4% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -205193000.0 | +38.1% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 330338000.0 | +261.0% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 168498000.0 | -49.0% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 137624000.0 | -18.3% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -132209000.0 | -196.1% | USD | 10-K | 2026-02-27 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-06-30 | 10238000.0 | — | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 10692000.0 | +4.4% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 413000.0 | -96.1% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 2442000.0 | +491.3% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 78337000.0 | +3107.9% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 564000.0 | -99.3% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 6052000.0 | +973.0% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | 110695000.0 | +1729.1% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 2578000.0 | -97.7% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | 115725000.0 | +4388.9% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | 120158000.0 | +3.8% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 3826000.0 | -96.8% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | 213430000.0 | +5478.4% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 489053000.0 | +129.1% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 4570000.0 | -99.1% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 12914000.0 | +182.6% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 567673000.0 | +4295.8% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 4156000.0 | -99.3% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 13074000.0 | +214.6% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 14467000.0 | +10.7% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 2301000.0 | -84.1% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 11613000.0 | +404.7% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 247616000.0 | +2032.2% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 6466000.0 | -97.4% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 17510000.0 | +170.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 19230000.0 | +9.8% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 544000.0 | -97.2% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 13120000.0 | +2311.8% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 15055000.0 | +14.7% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 13184000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 80372000.0 | +509.6% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | 113725000.0 | +41.5% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | 340774000.0 | +199.6% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | 500847000.0 | +47.0% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | 576188000.0 | +15.0% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 482640000.0 | -16.2% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 254461000.0 | -47.3% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 30204000.0 | -88.1% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 47461000.0 | +57.1% | USD | 10-K | 2026-02-27 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3484000.0 | — | USD | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 7311000.0 | +109.8% | USD | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 14577000.0 | +99.4% | USD | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 6338000.0 | -56.5% | USD | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 8066000.0 | +27.3% | USD | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 9147000.0 | +13.4% | USD | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 852000.0 | -90.7% | USD | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 1227000.0 | +44.0% | USD | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | 1770000.0 | +44.3% | USD | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 955000.0 | -46.0% | USD | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | 1599000.0 | +67.4% | USD | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | 2554000.0 | +59.7% | USD | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 7917000.0 | +210.0% | USD | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | 10130000.0 | +28.0% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 12073000.0 | +19.2% | USD | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 10260000.0 | -15.0% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 18891000.0 | +84.1% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 32027000.0 | +69.5% | USD | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 15885000.0 | -50.4% | USD | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 23661000.0 | +49.0% | USD | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 35870000.0 | +51.6% | USD | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 11380000.0 | -68.3% | USD | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 20190000.0 | +77.4% | USD | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 29147000.0 | +44.4% | USD | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 20315000.0 | -30.3% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 31993000.0 | +57.5% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 48305000.0 | +51.0% | USD | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 21815000.0 | -54.8% | USD | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 47712000.0 | +118.7% | USD | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 70117000.0 | +47.0% | USD | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 23136000.0 | — | USD | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 9867000.0 | -57.4% | USD | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | 3880000.0 | -60.7% | USD | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | 4968000.0 | +28.0% | USD | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | 19604000.0 | +294.6% | USD | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | 41030000.0 | +109.3% | USD | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 47697000.0 | +16.2% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 39199000.0 | -17.8% | USD | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 66423000.0 | +69.5% | USD | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 106188000.0 | +59.9% | USD | 10-K | 2026-02-27 |
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-12-31 | 52665000.0 | — | shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 52808000.0 | +0.3% | shares | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 53208000.0 | +0.8% | shares | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 53708000.0 | +0.9% | shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 54040000.0 | +0.6% | shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 54251000.0 | +0.4% | shares | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 55454000.0 | +2.2% | shares | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 61673000.0 | +11.2% | shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 62083000.0 | +0.7% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 63340000.0 | +2.0% | shares | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 70035000.0 | +10.6% | shares | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 70850000.0 | +1.2% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 78005000.0 | +10.1% | shares | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 78652000.0 | +0.8% | shares | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 79717000.0 | +1.4% | shares | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 85281000.0 | +7.0% | shares | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 86223000.0 | +1.1% | shares | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 87430000.0 | +1.4% | shares | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 88498000.0 | +1.2% | shares | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 94538000.0 | +6.8% | shares | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 95140000.0 | +0.6% | shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 96259000.0 | +1.2% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 96903000.0 | +0.7% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 97300000.0 | +0.4% | shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 111255000.0 | +14.3% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 113359000.0 | +1.9% | shares | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 114051000.0 | +0.6% | shares | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 118990000.0 | +4.3% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 119581000.0 | +0.5% | shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 122234000.0 | +2.2% | shares | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 123365000.0 | +0.9% | shares | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 124137000.0 | +0.6% | shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 132646000.0 | +6.9% | shares | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 135932000.0 | +2.5% | shares | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 136757000.0 | +0.6% | shares | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 137533000.0 | +0.6% | shares | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 52665000.0 | — | shares | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 54040000.0 | +2.6% | shares | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 62083000.0 | +14.9% | shares | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 78005000.0 | +25.6% | shares | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 86223000.0 | +10.5% | shares | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 95140000.0 | +10.3% | shares | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 111255000.0 | +16.9% | shares | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 119581000.0 | +7.5% | shares | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 132646000.0 | +10.9% | shares | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 139693000.0 | +5.3% | shares | 10-K | 2026-02-27 |
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-12-31 | 52665000.0 | — | shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 52808000.0 | +0.3% | shares | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 53208000.0 | +0.8% | shares | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 53708000.0 | +0.9% | shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 54040000.0 | +0.6% | shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 54251000.0 | +0.4% | shares | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 55454000.0 | +2.2% | shares | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 61673000.0 | +11.2% | shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 62083000.0 | +0.7% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 63340000.0 | +2.0% | shares | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 70035000.0 | +10.6% | shares | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 70850000.0 | +1.2% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 78005000.0 | +10.1% | shares | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 78652000.0 | +0.8% | shares | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 79717000.0 | +1.4% | shares | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 85281000.0 | +7.0% | shares | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 86223000.0 | +1.1% | shares | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 87430000.0 | +1.4% | shares | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 88498000.0 | +1.2% | shares | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 94538000.0 | +6.8% | shares | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 95140000.0 | +0.6% | shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 96259000.0 | +1.2% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 96903000.0 | +0.7% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 97300000.0 | +0.4% | shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-11-30 | 13144500.0 | -86.5% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2022-12-31 | 111255000.0 | +746.4% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 113359000.0 | +1.9% | shares | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 114051000.0 | +0.6% | shares | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 118990000.0 | +4.3% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 119581000.0 | +0.5% | shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 122234000.0 | +2.2% | shares | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 123365000.0 | +0.9% | shares | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 124137000.0 | +0.6% | shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 132646000.0 | +6.9% | shares | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 135932000.0 | +2.5% | shares | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 136757000.0 | +0.6% | shares | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 137533000.0 | +0.6% | shares | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 52665000.0 | — | shares | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 54040000.0 | +2.6% | shares | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 62083000.0 | +14.9% | shares | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 78005000.0 | +25.6% | shares | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 86223000.0 | +10.5% | shares | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 95140000.0 | +10.3% | shares | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 111255000.0 | +16.9% | shares | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 119581000.0 | +7.5% | shares | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 132646000.0 | +10.9% | shares | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 139693000.0 | +5.3% | shares | 10-K | 2026-02-27 |
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 50439000.0 | — | shares | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 51445000.0 | +2.0% | shares | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 52012000.0 | +1.1% | shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 52758000.0 | +1.4% | shares | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 53088000.0 | +0.6% | shares | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 53447000.0 | +0.7% | shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 54132000.0 | +1.3% | shares | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 54551000.0 | +0.8% | shares | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | 60570000.0 | +11.0% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 62831000.0 | +3.7% | shares | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 68224000.0 | +8.6% | shares | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 70456000.0 | +3.3% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2021-03-31 | 86689000.0 | +23.0% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 88077000.0 | +1.6% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 92558000.0 | +5.1% | shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 95578000.0 | +3.3% | shares | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 96579000.0 | +1.0% | shares | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 97052000.0 | +0.5% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 111767000.0 | +15.2% | shares | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 113690000.0 | +1.7% | shares | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 115171000.0 | +1.3% | shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 120814000.0 | +4.9% | shares | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 122853000.0 | +1.7% | shares | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 123775000.0 | +0.8% | shares | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 134750000.0 | +8.9% | shares | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 136388000.0 | +1.2% | shares | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 137187000.0 | +0.6% | shares | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 51576000.0 | — | shares | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 53312000.0 | +3.4% | shares | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | 57848000.0 | +8.5% | shares | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 69555000.0 | +20.2% | shares | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | 81011000.0 | +16.5% | shares | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | 90558000.0 | +11.8% | shares | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 98408000.0 | +8.7% | shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 114997000.0 | +16.9% | shares | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 124718000.0 | +8.5% | shares | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 136721000.0 | +9.6% | shares | 10-K | 2026-02-27 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 50439000.0 | — | shares | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 51445000.0 | +2.0% | shares | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 52012000.0 | +1.1% | shares | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 53043000.0 | +2.0% | shares | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 53088000.0 | +0.1% | shares | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 53447000.0 | +0.7% | shares | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 54132000.0 | +1.3% | shares | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 54551000.0 | +0.8% | shares | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | 60570000.0 | +11.0% | shares | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 62831000.0 | +3.7% | shares | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | 68224000.0 | +8.6% | shares | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | 70456000.0 | +3.3% | shares | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 78287000.0 | +11.1% | shares | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | 79069000.0 | +1.0% | shares | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 80908000.0 | +2.3% | shares | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 86689000.0 | +7.1% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 88077000.0 | +1.6% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 92558000.0 | +5.1% | shares | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 95578000.0 | +3.3% | shares | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 96579000.0 | +1.0% | shares | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 97052000.0 | +0.5% | shares | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 111767000.0 | +15.2% | shares | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 113690000.0 | +1.7% | shares | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 115171000.0 | +1.3% | shares | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 120814000.0 | +4.9% | shares | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 122853000.0 | +1.7% | shares | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 123775000.0 | +0.8% | shares | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 134750000.0 | +8.9% | shares | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 136388000.0 | +1.2% | shares | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 137187000.0 | +0.6% | shares | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 51576000.0 | — | shares | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 53604000.0 | +3.9% | shares | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | 57848000.0 | +7.9% | shares | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | 69555000.0 | +20.2% | shares | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | 81011000.0 | +16.5% | shares | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | 90558000.0 | +11.8% | shares | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 98408000.0 | +8.7% | shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 114997000.0 | +16.9% | shares | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 124718000.0 | +8.5% | shares | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 136721000.0 | +9.6% | shares | 10-K | 2026-02-27 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 9Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.2329 | — | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 0.1990 | -14.6% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 0.2223 | +11.7% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 0.2664 | +19.8% | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 0.3300 | +23.9% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 0.2740 | -17.0% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 0.2851 | +4.1% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 0.3245 | +13.8% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | 0.2354 | -27.5% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 0.2556 | +8.6% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | 0.1940 | -24.1% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | 0.2049 | +5.6% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 0.1683 | -17.9% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | 0.1196 | -29.0% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 0.1005 | -16.0% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 0.1705 | +69.6% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.1671 | -2.0% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 0.1206 | -27.8% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 0.1696 | +40.7% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | 0.1858 | +9.5% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | 0.2087 | +12.4% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 0.1833 | -12.2% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | 0.2095 | +14.3% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | 0.1855 | -11.5% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 0.2505 | +35.0% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | 0.2725 | +8.8% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | 0.2764 | +1.4% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 0.2897 | +4.8% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 0.3111 | +7.4% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 0.3251 | +4.5% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 1.0087 | — | ratio | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 0.9768 | -3.2% | ratio | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | 0.9608 | -1.6% | ratio | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | 0.5189 | -46.0% | ratio | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | 0.4195 | -19.2% | ratio | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | 0.5059 | +20.6% | ratio | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | 0.5882 | +16.3% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.7509 | +27.7% | ratio | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | 1.0218 | +36.1% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 0.9615 | -5.9% | ratio | 10-K | 2026-02-27 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2.9544 | — | ratio | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 2.4838 | -15.9% | ratio | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 2.2117 | -11.0% | ratio | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 1.8059 | -18.3% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 1.5069 | -16.6% | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 1.2527 | -16.9% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 1.8490 | +47.6% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 1.7111 | -7.5% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 1.7965 | +5.0% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 1.6852 | -6.2% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 2.4422 | +44.9% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 2.1102 | -13.6% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 1.8470 | -12.5% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 2.5367 | +37.3% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 2.3464 | -7.5% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 2.9085 | +24.0% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 2.8148 | -3.2% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 3.7794 | +34.3% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 4.6766 | +23.7% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 4.3338 | -7.3% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 4.7398 | +9.4% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 3.7370 | -21.2% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 5.9646 | +59.6% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 4.9925 | -16.3% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 4.2421 | -15.0% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 3.5830 | -15.5% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 3.1040 | -13.4% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 3.9028 | +25.7% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 3.8817 | -0.5% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 3.8486 | -0.9% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 4.3711 | +13.6% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 4.0959 | -6.3% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 4.1231 | +0.7% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 4.1383 | +0.4% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 4.3878 | +6.0% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 3.9990 | -8.9% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 3.8733 | -3.1% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 3.7200 | -4.0% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 3.2744 | -12.0% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 1.8059 | — | ratio | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 1.7111 | -5.2% | ratio | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 2.1102 | +23.3% | ratio | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 2.9085 | +37.8% | ratio | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 4.3338 | +49.0% | ratio | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 4.9925 | +15.2% | ratio | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 3.9028 | -21.8% | ratio | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 4.0959 | +4.9% | ratio | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 3.9990 | -2.4% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 3.3927 | -15.2% | ratio | 10-K | 2026-02-27 |
Debt to Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.4634 | — | ratio | 10-Q | 2016-05-13 |
| Quarterly | 2016-06-30 | 0.5949 | +28.4% | ratio | 10-Q | 2016-08-11 |
| Quarterly | 2016-09-30 | 0.7274 | +22.3% | ratio | 10-Q | 2016-11-14 |
| Quarterly | 2016-12-31 | 0.9787 | +34.5% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | 1.3893 | +42.0% | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2017-06-30 | 2.1120 | +52.0% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2017-09-30 | 5.7604 | +172.7% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-12-31 | 7.4437 | +29.2% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -57.4125 | -871.3% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | -9.8198 | +82.9% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 3.9020 | +139.7% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 7.3381 | +88.1% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 51.4358 | +600.9% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 3.1179 | -93.9% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 3.4897 | +11.9% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 1.0905 | -68.7% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 1.1575 | +6.1% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 1.3771 | +19.0% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 0.8222 | -40.3% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 0.9171 | +11.5% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 1.3990 | +52.6% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 1.8416 | +31.6% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 0.7277 | -60.5% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 0.8927 | +22.7% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 1.1106 | +24.4% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 1.4000 | +26.1% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 1.7905 | +27.9% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-12-31 | 0.9759 | -45.5% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | 1.0273 | +5.3% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2023-06-30 | 1.0933 | +6.4% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2023-09-30 | 0.8435 | -22.8% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-12-31 | 0.8838 | +4.8% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | 0.8489 | -3.9% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2024-06-30 | 0.8135 | -4.2% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2024-09-30 | 0.8109 | -0.3% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-12-31 | 0.3892 | -52.0% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | 0.3974 | +2.1% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | 0.4100 | +3.2% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | 0.4546 | +10.9% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 0.7258 | — | ratio | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 7.4437 | +925.6% | ratio | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 7.3381 | -1.4% | ratio | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 1.0905 | -85.1% | ratio | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 0.9171 | -15.9% | ratio | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 0.8927 | -2.7% | ratio | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 0.9759 | +9.3% | ratio | 10-K | 2024-02-29 |
| Annual | 2023-12-31 | 0.8838 | -9.4% | ratio | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 0.3892 | -56.0% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | 0.4006 | +2.9% | ratio | 10-K | 2026-02-27 |
Gross Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2024-09-30 | 1.6453 | — | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | 0.0532 | — | ratio | 10-K | 2018-03-15 |
| Annual | 2017-12-31 | 0.0731 | +37.5% | ratio | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 0.0938 | +28.3% | ratio | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 0.1283 | +36.7% | ratio | 10-K | 2020-03-02 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.1403 | — | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -0.6125 | -336.6% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -1.0737 | -75.3% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -0.7138 | +33.5% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -1.1963 | -67.6% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -1.6171 | -35.2% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -0.5273 | +67.4% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -1.0575 | -100.5% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -1.4754 | -39.5% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -0.5102 | +65.4% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -0.8945 | -75.3% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -1.1506 | -28.6% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -0.3762 | +67.3% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -1.0987 | -192.0% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -1.5623 | -42.2% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -0.4192 | +73.2% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -1.2665 | -202.1% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -2.0944 | -65.4% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -0.7139 | +65.9% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -1.4316 | -100.5% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -1.9238 | -34.4% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -0.5664 | +70.6% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -0.9477 | -67.3% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -1.3297 | -40.3% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -0.1838 | +86.2% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -0.2542 | -38.3% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -0.3108 | -22.3% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -0.1334 | +57.1% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -0.3071 | -130.3% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -0.4313 | -40.4% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -0.4721 | — | ratio | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -0.6565 | -39.1% | ratio | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -0.4974 | +24.2% | ratio | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -0.4129 | +17.0% | ratio | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -0.5876 | -42.3% | ratio | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -0.7542 | -28.4% | ratio | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -0.6679 | +11.4% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -0.4016 | +39.9% | ratio | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -0.1122 | +72.1% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -0.0903 | +19.6% | ratio | 10-K | 2026-02-27 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.1552 | — | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -0.4331 | -179.1% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -0.4946 | -14.2% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -0.7367 | -48.9% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -0.5426 | +26.3% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -0.4613 | +15.0% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -0.4895 | -6.1% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -0.4316 | +11.8% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -0.4161 | +3.6% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -0.4751 | -14.2% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -0.3851 | +18.9% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -0.2708 | +29.7% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -0.3709 | -37.0% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -0.5974 | -61.1% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.5683 | +4.9% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -0.4137 | +27.2% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -0.8118 | -96.2% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -0.9499 | -17.0% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -0.7064 | +25.6% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -0.7219 | -2.2% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -0.5652 | +21.7% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -0.5721 | -1.2% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -0.4301 | +24.8% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -0.4136 | +3.8% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -0.2021 | +51.1% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -0.1062 | +47.4% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -0.0895 | +15.8% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -0.1578 | -76.4% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -0.2019 | -28.0% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -0.1648 | +18.4% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -0.4755 | — | ratio | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -0.6456 | -35.8% | ratio | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -0.4449 | +31.1% | ratio | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -0.3846 | +13.5% | ratio | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -0.5531 | -43.8% | ratio | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -0.7485 | -35.3% | ratio | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -0.6596 | +11.9% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -0.4122 | +37.5% | ratio | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -0.1310 | +68.2% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -0.1344 | -2.6% | ratio | 10-K | 2026-02-27 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.4038 | — | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | 0.1734 | -57.1% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | 0.2638 | +52.2% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2016-12-31 | 0.1582 | -40.0% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2017-03-31 | 0.0977 | -38.3% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | 0.0726 | -25.6% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | 0.1225 | +68.6% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2017-12-31 | 0.1196 | -2.4% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 0.3226 | +169.8% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2018-06-30 | 0.1254 | -61.1% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2018-09-30 | 0.3391 | +170.4% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-12-31 | 0.4071 | +20.1% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | 0.3043 | -25.3% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2019-06-30 | 0.2358 | -22.5% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2019-09-30 | 0.3740 | +58.6% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-12-31 | 0.3443 | -8.0% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | 0.4197 | +21.9% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2020-06-30 | 0.4404 | +4.9% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2020-09-30 | 1.0688 | +142.7% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-12-31 | 0.2445 | -77.1% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | 0.3900 | +59.5% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2021-06-30 | 0.3172 | -18.7% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 0.4762 | +50.1% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-12-31 | 0.3854 | -19.1% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | 0.6851 | +77.8% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 0.3628 | -47.0% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 0.2134 | -41.2% | ratio | 10-Q | 2022-11-09 |
| Annual | 2016-12-31 | 0.1582 | — | ratio | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | 0.1196 | -24.4% | ratio | 10-K | 2019-03-15 |
| Annual | 2018-12-31 | 0.4071 | +240.6% | ratio | 10-K | 2020-03-02 |
| Annual | 2019-12-31 | 0.3443 | -15.4% | ratio | 10-K | 2021-02-26 |
| Annual | 2020-12-31 | 0.2445 | -29.0% | ratio | 10-K | 2022-02-25 |
| Annual | 2021-12-31 | 0.3854 | +57.6% | ratio | 10-K | 2023-03-01 |
| Annual | 2022-12-31 | 1.5008 | +289.4% | ratio | 10-K | 2023-03-01 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.0327 | — | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -0.1219 | -272.9% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -0.2387 | -95.9% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -0.1902 | +20.3% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -0.3948 | -107.6% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -0.4431 | -12.2% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | -0.1503 | +66.1% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | -0.3432 | -128.3% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -0.3473 | -1.2% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -0.1304 | +62.5% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -0.1735 | -33.1% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -0.2358 | -35.9% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -0.0633 | +73.1% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -0.1314 | -107.5% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.1570 | -19.5% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -0.0715 | +54.5% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -0.2116 | -196.1% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -0.2525 | -19.3% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -0.1211 | +52.1% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -0.2659 | -119.6% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -0.4016 | -51.0% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -0.1038 | +74.1% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -0.1985 | -91.2% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -0.2466 | -24.2% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -0.0460 | +81.3% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -0.0693 | -50.4% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -0.0859 | -24.0% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -0.0386 | +55.0% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -0.0955 | -147.3% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -0.1402 | -46.8% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -0.4762 | — | ratio | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -0.6413 | -34.7% | ratio | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -0.4779 | +25.5% | ratio | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -0.2142 | +55.2% | ratio | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -0.2465 | -15.0% | ratio | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -0.3815 | -54.8% | ratio | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -0.3928 | -3.0% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -0.3016 | +23.2% | ratio | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -0.1147 | +62.0% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -0.0868 | +24.3% | ratio | 10-K | 2026-02-27 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.0478 | — | ratio | 10-Q | 2017-05-10 |
| Quarterly | 2016-06-30 | -0.1944 | -306.4% | ratio | 10-Q | 2017-08-09 |
| Quarterly | 2016-09-30 | -0.4123 | -112.1% | ratio | 10-Q | 2017-11-09 |
| Quarterly | 2017-03-31 | -0.4544 | -10.2% | ratio | 10-Q | 2018-05-10 |
| Quarterly | 2017-06-30 | -1.2286 | -170.4% | ratio | 10-Q | 2018-08-09 |
| Quarterly | 2017-09-30 | -2.9953 | -143.8% | ratio | 10-Q | 2018-11-09 |
| Quarterly | 2018-03-31 | 8.4812 | +383.1% | ratio | 10-Q | 2019-05-10 |
| Quarterly | 2018-06-30 | 3.0266 | -64.3% | ratio | 10-Q | 2019-08-09 |
| Quarterly | 2018-09-30 | -1.7025 | -156.3% | ratio | 10-Q | 2019-11-08 |
| Quarterly | 2019-03-31 | -6.8373 | -301.6% | ratio | 10-Q | 2020-05-08 |
| Quarterly | 2019-06-30 | -0.7145 | +89.6% | ratio | 10-Q | 2020-08-07 |
| Quarterly | 2019-09-30 | -1.0584 | -48.1% | ratio | 10-Q | 2020-11-06 |
| Quarterly | 2020-03-31 | -0.1366 | +87.1% | ratio | 10-Q | 2021-05-07 |
| Quarterly | 2020-06-30 | -0.3123 | -128.6% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.2861 | +8.4% | ratio | 10-Q | 2021-11-05 |
| Quarterly | 2021-03-31 | -0.1714 | +40.1% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -0.6014 | -250.8% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -0.4363 | +27.5% | ratio | 10-Q | 2022-11-09 |
| Quarterly | 2022-03-31 | -0.2556 | +41.4% | ratio | 10-Q | 2023-05-10 |
| Quarterly | 2022-06-30 | -0.6382 | -149.7% | ratio | 10-Q | 2023-08-04 |
| Quarterly | 2022-09-30 | -1.1206 | -75.6% | ratio | 10-Q | 2023-11-09 |
| Quarterly | 2023-03-31 | -0.2105 | +81.2% | ratio | 10-Q | 2024-05-10 |
| Quarterly | 2023-06-30 | -0.4156 | -97.4% | ratio | 10-Q | 2024-08-09 |
| Quarterly | 2023-09-30 | -0.4547 | -9.4% | ratio | 10-Q | 2024-11-12 |
| Quarterly | 2024-03-31 | -0.0851 | +81.3% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2024-06-30 | -0.1256 | -47.5% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2024-09-30 | -0.1556 | -23.9% | ratio | 10-Q | 2025-11-07 |
| Quarterly | 2025-03-31 | -0.0540 | +65.3% | ratio | 10-Q | 2025-05-09 |
| Quarterly | 2025-06-30 | -0.1347 | -149.5% | ratio | 10-Q | 2025-08-08 |
| Quarterly | 2025-09-30 | -0.2040 | -51.4% | ratio | 10-Q | 2025-11-07 |
| Annual | 2016-12-31 | -0.6988 | — | ratio | 10-K | 2019-03-15 |
| Annual | 2017-12-31 | -5.4148 | -674.9% | ratio | 10-K | 2020-03-02 |
| Annual | 2018-12-31 | -3.9846 | +26.4% | ratio | 10-K | 2021-02-26 |
| Annual | 2019-12-31 | -0.4479 | +88.8% | ratio | 10-K | 2022-02-25 |
| Annual | 2020-12-31 | -0.4725 | -5.5% | ratio | 10-K | 2023-03-01 |
| Annual | 2021-12-31 | -0.7220 | -52.8% | ratio | 10-K | 2024-02-29 |
| Annual | 2022-12-31 | -0.7762 | -7.5% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -0.5681 | +26.8% | ratio | 10-K | 2026-02-27 |
| Annual | 2024-12-31 | -0.1593 | +72.0% | ratio | 10-K | 2026-02-27 |
| Annual | 2025-12-31 | -0.1216 | +23.7% | ratio | 10-K | 2026-02-27 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 58,292 | $0.00 | $0 | 0 |
| 2026-04-06 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Other disposed transaction
F
|
Common Stock | 27,610 | $204.87 | $5,656,461 | 2,383,162 |
| 2026-04-06 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 58,292 | $9.59 | $559,020 | 2,410,772 |
| 2026-04-01 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,909 | $205.00 | $391,350 | 224,885 |
| 2026-04-01 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,200 | $203.83 | $244,591 | 226,794 |
| 2026-04-01 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 3,213 | $203.07 | $652,470 | 227,994 |
| 2026-04-01 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,778 | $202.01 | $359,167 | 231,207 |
| 2026-04-01 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 300 | $200.79 | $60,236 | 232,985 |
| 2026-03-31 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 41,708 | $0.00 | $0 | 58,292 |
| 2026-03-31 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 41,708 | $9.59 | $399,980 | 2,352,480 |
| 2026-03-20 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 280 | $200.90 | $56,253 | 21,032 |
| 2026-03-20 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 235 | $199.88 | $46,971 | 21,312 |
| 2026-03-20 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 371 | $200.97 | $74,561 | 21,032 |
| 2026-03-20 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 140 | $199.82 | $27,975 | 21,403 |
| 2026-03-20 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 239 | $198.85 | $47,526 | 21,543 |
| 2026-03-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,814 | $198.65 | $360,355 | 259,255 |
| 2026-03-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 956 | $197.84 | $189,135 | 261,069 |
| 2026-03-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 300 | $196.27 | $58,880 | 262,025 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 50,000 | $0.00 | $0 | 100,000 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 254 | $198.02 | $50,297 | 2,310,772 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 16,457 | $197.22 | $3,245,612 | 2,311,026 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 24,814 | $196.23 | $4,869,291 | 2,327,483 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 4,875 | $195.42 | $952,696 | 2,352,297 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 2,300 | $194.17 | $446,593 | 2,357,172 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 900 | $192.43 | $173,185 | 2,359,472 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 300 | $190.68 | $57,203 | 2,360,372 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 100 | $190.07 | $19,007 | 2,360,672 |
| 2026-03-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 50,000 | $9.59 | $479,500 | 2,360,772 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 75,000 | $0.00 | $0 | 150,000 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 1,100 | $191.22 | $210,345 | 2,310,772 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 13,883 | $190.46 | $2,644,206 | 2,311,872 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 21,504 | $189.50 | $4,075,006 | 2,325,755 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 21,476 | $188.54 | $4,049,190 | 2,347,259 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 17,037 | $187.63 | $3,196,632 | 2,368,735 |
| 2026-03-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 75,000 | $9.59 | $719,250 | 2,385,772 |
| 2026-03-13 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 122 | $191.38 | $23,348 | 5,752 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 75,000 | $0.00 | $0 | 225,000 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 100 | $195.32 | $19,532 | 2,310,772 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 4,082 | $194.57 | $794,218 | 2,310,872 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 7,043 | $193.58 | $1,363,389 | 2,314,954 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 8,579 | $192.79 | $1,653,957 | 2,321,997 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 9,896 | $191.55 | $1,895,595 | 2,330,576 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 22,063 | $190.53 | $4,203,721 | 2,340,472 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 2,886 | $189.64 | $547,307 | 2,362,535 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 6,451 | $188.52 | $1,216,112 | 2,365,421 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 5,809 | $187.52 | $1,089,300 | 2,371,872 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 8,091 | $186.75 | $1,510,989 | 2,377,681 |
| 2026-03-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 75,000 | $9.59 | $719,250 | 2,385,772 |
| 2026-03-10 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 785 | $204.13 | $160,244 | 63,354 |
| 2026-03-09 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Equity grant / award
A
|
Common Stock | 1,968 | — | — | 64,139 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 5,598 | $0.00 | $0 | 0 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,998 | $198.04 | $395,694 | 233,285 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,500 | $196.94 | $295,406 | 235,283 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,600 | $195.80 | $313,273 | 236,783 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 2,900 | $194.77 | $564,832 | 238,383 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 400 | $193.73 | $77,491 | 241,283 |
| 2026-03-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 5,598 | $19.68 | $110,169 | 241,683 |
| 2026-03-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $202.85 | $20,285 | 262,194 |
| 2026-03-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,400 | $200.42 | $481,012 | 262,394 |
| 2026-03-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 470 | $198.50 | $93,293 | 264,794 |
| 2026-02-27 | Sheena Jonathan | — |
Equity grant / award
A
|
Common Stock | 2,103 | — | — | 265,264 |
| 2026-02-03 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,639 | $230.77 | $378,229 | 137,847 |
| 2026-02-03 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 4,971 | $227.45 | $1,130,639 | 52,120 |
| 2026-02-03 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 700 | $225.25 | $157,674 | 57,091 |
| 2026-02-03 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,268 | $230.77 | $292,614 | 57,791 |
| 2026-02-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 16 | $234.00 | $3,744 | 139,486 |
| 2026-02-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 600 | $233.24 | $139,942 | 139,502 |
| 2026-02-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 850 | $232.33 | $197,477 | 140,102 |
| 2026-02-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 576 | $230.84 | $132,964 | 140,952 |
| 2026-02-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 878 | $229.96 | $201,903 | 141,528 |
| 2026-02-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 80 | $228.50 | $18,280 | 142,406 |
| 2026-01-30 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Equity grant / award
A
|
Common Stock | 6,135 | — | — | 181,675 |
| 2026-01-28 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,648 | $237.66 | $866,992 | 213,180 |
| 2026-01-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,322 | $240.53 | $558,514 | 216,828 |
| 2026-01-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 390 | $244.87 | $95,500 | 21,782 |
| 2026-01-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $242.23 | $48,446 | 22,332 |
| 2026-01-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 50 | $245.62 | $12,281 | 21,782 |
| 2026-01-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 355 | $244.78 | $86,897 | 21,832 |
| 2026-01-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 185 | $243.49 | $45,046 | 22,187 |
| 2026-01-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 160 | $243.59 | $38,974 | 22,172 |
| 2026-01-21 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,590 | $235.00 | $373,650 | 219,150 |
| 2026-01-20 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,386 | $0.00 | $0 | 0 |
| 2026-01-20 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,386 | — | — | 220,740 |
| 2026-01-20 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 71,932 | $234.74 | $16,885,203 | 217,354 |
| 2026-01-14 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Equity grant / award
A
|
Common Stock | 59,596 | $0.00 | $0 | 123,722 |
| 2026-01-05 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 39,615 | $0.00 | $0 | 0 |
| 2026-01-05 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 39,615 | $9.59 | $379,908 | 262,581 |
| 2026-01-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,659 | $229.43 | $380,620 | 123,499 |
| 2026-01-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,292 | $228.33 | $295,002 | 125,158 |
| 2025-12-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 550 | $226.34 | $124,489 | 22,532 |
| 2025-12-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $224.74 | $44,948 | 23,082 |
| 2025-12-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 130 | $228.28 | $29,677 | 222,966 |
| 2025-12-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,348 | $227.44 | $306,583 | 223,096 |
| 2025-12-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,592 | $226.54 | $360,652 | 224,444 |
| 2025-12-15 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
G
|
Common Stock | 115 | $0.00 | $0 | 126,450 |
| 2025-12-15 | Sheena Jonathan | — |
Equity grant / award
G
|
Common Stock | 1,060 | $0.00 | $0 | 226,036 |
| 2025-12-12 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 150 | $229.09 | $34,364 | 20,342 |
| 2025-12-12 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 11,987 | $228.49 | $2,738,859 | 20,492 |
| 2025-12-12 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 21,910 | $227.35 | $4,981,309 | 32,479 |
| 2025-12-12 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 14,372 | $226.62 | $3,256,945 | 54,389 |
| 2025-12-12 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Exercise / conversion
M
|
Common Stock | 13,500 | $9.59 | $129,465 | 126,565 |
| 2025-12-12 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 4,692 | $230.76 | $1,082,714 | 113,065 |
| 2025-12-12 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Exercise / conversion
M
|
Common Stock | 8,876 | $9.59 | $85,121 | 117,757 |
| 2025-12-12 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
G
|
Common Stock | 180 | $0.00 | $0 | 108,881 |
| 2025-12-10 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 22,376 | $0.00 | $0 | 5,125 |
| 2025-12-09 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 4,436 | $0.00 | $0 | 5,544 |
| 2025-12-09 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 4,436 | $9.29 | $41,210 | 227,096 |
| 2025-12-05 | Chapman Rowan E | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 4,000 | $0.00 | $0 | 7,000 |
| 2025-12-05 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 366 | $243.39 | $89,081 | 5,777 |
| 2025-12-05 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 4,000 | $243.08 | $972,308 | 6,143 |
| 2025-12-05 | Chapman Rowan E | — |
Exercise / conversion
M
|
Common Stock | 4,000 | $32.15 | $128,600 | 10,143 |
| 2025-12-04 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 6,902 | $0.00 | $0 | 5,598 |
| 2025-12-04 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 6,902 | $19.68 | $135,831 | 208,601 |
| 2025-12-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 474 | $239.53 | $113,535 | 109,061 |
| 2025-12-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,527 | $238.24 | $363,797 | 109,535 |
| 2025-12-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 250 | $237.77 | $59,443 | 111,062 |
| 2025-12-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 749 | $237.23 | $177,683 | 111,312 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 500 | $239.11 | $119,555 | 1,154,198 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 18,839 | $238.57 | $4,494,418 | 1,154,698 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 15,336 | $237.69 | $3,645,260 | 1,173,537 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 6,173 | $236.54 | $1,460,149 | 1,188,873 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 9,623 | $235.65 | $2,267,672 | 1,195,046 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 9,991 | $234.55 | $2,343,401 | 1,204,669 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 7,032 | $233.66 | $1,643,098 | 1,214,660 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 3,606 | $232.75 | $839,308 | 1,221,692 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 900 | $231.23 | $208,110 | 1,225,298 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $230.03 | $230,030 | 1,226,198 |
| 2025-11-24 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 2,000 | $228.97 | $457,934 | 1,227,198 |
| 2025-11-21 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,000 | $230.01 | $460,011 | 23,282 |
| 2025-11-20 | Baynes Roy D. | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 7,068 | $0.00 | $0 | 0 |
| 2025-11-20 | Baynes Roy D. | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 600 | $0.00 | $0 | 0 |
| 2025-11-20 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,884 | $224.89 | $423,685 | 18,359 |
| 2025-11-20 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,900 | $223.90 | $425,417 | 20,243 |
| 2025-11-20 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,800 | $222.90 | $401,220 | 22,143 |
| 2025-11-20 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 900 | $221.81 | $199,632 | 23,943 |
| 2025-11-20 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,184 | $220.14 | $260,646 | 24,843 |
| 2025-11-20 | Baynes Roy D. | — |
Exercise / conversion
M
|
Common Stock | 7,068 | $41.19 | $291,131 | 26,027 |
| 2025-11-20 | Baynes Roy D. | — |
Exercise / conversion
M
|
Common Stock | 600 | $40.93 | $24,558 | 18,959 |
| 2025-11-20 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 10,000 | $225.08 | $2,250,816 | 222,660 |
| 2025-11-19 | Baynes Roy D. | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,112 | $0.00 | $0 | 600 |
| 2025-11-19 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 2,135 | $216.07 | $461,304 | 18,359 |
| 2025-11-19 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,727 | $214.79 | $370,946 | 20,494 |
| 2025-11-19 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,250 | $213.47 | $266,839 | 22,221 |
| 2025-11-19 | Baynes Roy D. | — |
Exercise / conversion
M
|
Common Stock | 5,112 | $40.93 | $209,234 | 23,471 |
| 2025-11-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 170 | $209.28 | $35,578 | 25,282 |
| 2025-11-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 390 | $207.94 | $81,097 | 25,452 |
| 2025-11-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 190 | $206.86 | $39,304 | 25,842 |
| 2025-11-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 163 | $209.28 | $34,113 | 25,282 |
| 2025-11-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 382 | $207.95 | $79,435 | 25,445 |
| 2025-11-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 205 | $206.86 | $42,407 | 25,827 |
| 2025-11-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $198.38 | $19,838 | 232,660 |
| 2025-11-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 600 | $196.06 | $117,633 | 232,860 |
| 2025-11-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 300 | $193.59 | $58,078 | 233,460 |
| 2025-11-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 400 | $192.64 | $77,055 | 233,760 |
| 2025-11-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 90 | $191.04 | $17,193 | 234,160 |
| 2025-11-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,480 | $190.33 | $281,685 | 234,250 |
| 2025-11-04 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 5,702 | $201.18 | $1,147,109 | 2,280,852 |
| 2025-11-04 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 17,198 | $200.29 | $3,444,565 | 2,286,554 |
| 2025-11-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,000 | $200.00 | $400,000 | 26,032 |
| 2025-10-31 | ROSENMAN HERM | — |
Equity grant / award
A
|
Common Stock | 132 | — | — | 68,761 |
| 2025-10-28 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,680 | $191.46 | $704,580 | 149,840 |
| 2025-10-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,335 | $192.32 | $449,077 | 153,520 |
| 2025-10-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 755 | $196.77 | $148,561 | 69,189 |
| 2025-10-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 495 | $187.16 | $92,644 | 69,944 |
| 2025-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 0 |
| 2025-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 70,439 |
| 2025-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 920 | $186.68 | $171,746 | 69,189 |
| 2025-10-21 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 292 | $187.95 | $54,881 | 117,267 |
| 2025-10-20 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 10,000 | $190.00 | $1,900,000 | 5,000 |
| 2025-10-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 337 | $179.29 | $60,421 | 28,032 |
| 2025-10-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 413 | $178.58 | $73,754 | 28,369 |
| 2025-10-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 275 | $179.35 | $49,322 | 28,032 |
| 2025-10-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 475 | $178.66 | $84,864 | 28,307 |
| 2025-10-15 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 423 | $176.63 | $74,712 | 236,112 |
| 2025-10-15 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 988 | $175.90 | $173,786 | 236,535 |
| 2025-10-15 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,506 | $175.11 | $263,715 | 237,523 |
| 2025-10-15 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 153 | $172.99 | $26,468 | 239,029 |
| 2025-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 780 | $160.70 | $125,347 | 117,559 |
| 2025-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,816 | $159.91 | $290,402 | 118,339 |
| 2025-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 404 | $158.96 | $64,220 | 120,155 |
| 2025-09-30 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,364 | $162.05 | $221,040 | 203,300 |
| 2025-09-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,500 | $0.00 | $0 | 0 |
| 2025-09-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 2,500 | — | — | 204,664 |
| 2025-09-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 380 | $180.68 | $68,659 | 28,782 |
| 2025-09-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,518 | $180.06 | $273,329 | 29,162 |
| 2025-09-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,602 | $179.09 | $645,093 | 30,680 |
| 2025-09-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 676 | $180.68 | $122,138 | 28,782 |
| 2025-09-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,380 | $179.88 | $248,240 | 29,458 |
| 2025-09-19 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,444 | $179.08 | $616,748 | 30,838 |
| 2025-09-19 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 1,188 | $181.28 | $215,363 | 2,320,852 |
| 2025-09-19 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 24,339 | $180.54 | $4,394,236 | 2,322,040 |
| 2025-09-18 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 14,473 | $180.13 | $2,607,069 | 2,346,379 |
| 2025-09-18 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 10,000 | $180.00 | $1,800,000 | 15,000 |
| 2025-09-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 256 | $176.61 | $45,212 | 239,182 |
| 2025-09-17 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,814 | $175.88 | $494,936 | 239,438 |
| 2025-09-15 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
G
|
Common Stock | 300 | $0.00 | $0 | 120,559 |
| 2025-09-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 500 | $172.64 | $86,320 | 25,000 |
| 2025-09-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 4,500 | $170.31 | $766,387 | 25,500 |
| 2025-09-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,907 | $167.69 | $319,779 | 158,514 |
| 2025-09-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,472 | $166.29 | $244,773 | 160,421 |
| 2025-09-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,700 | $165.44 | $281,243 | 161,893 |
| 2025-08-28 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 2,750 | $166.99 | $459,222 | 6,015 |
| 2025-08-14 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 8 | $155.42 | $1,243 | 123,859 |
| 2025-08-14 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 867 | $155.46 | $134,784 | 123,867 |
| 2025-08-12 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 1,675 | — | — | 124,734 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 20 | $156.32 | $3,126 | 34,282 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 610 | $155.74 | $95,003 | 34,302 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 270 | $154.04 | $41,592 | 34,912 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 180 | $152.40 | $27,432 | 35,182 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 300 | $151.12 | $45,337 | 35,362 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 120 | $149.56 | $17,948 | 35,662 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 639 | $155.80 | $99,553 | 34,282 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 191 | $154.60 | $29,528 | 34,921 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $152.73 | $30,546 | 35,112 |
| 2025-08-11 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 470 | $150.95 | $70,948 | 35,312 |
| 2025-08-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $164.51 | $32,902 | 242,252 |
| 2025-08-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 800 | $163.88 | $131,107 | 242,452 |
| 2025-08-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,030 | $162.73 | $167,616 | 243,252 |
| 2025-08-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 639 | $159.68 | $102,033 | 244,282 |
| 2025-08-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 301 | $158.63 | $47,748 | 244,921 |
| 2025-08-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $156.40 | $15,640 | 245,222 |
| 2025-08-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,997 | $133.31 | $399,538 | 163,593 |
| 2025-08-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,810 | $132.43 | $372,118 | 166,590 |
| 2025-07-28 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 6,092 | $139.81 | $851,712 | 169,400 |
| 2025-07-25 | Chapman Rowan E | — |
Equity grant / award
A
|
Common Stock | 149 | — | — | 8,765 |
| 2025-07-25 | Williams Brinkley Ruth | — |
Equity grant / award
A
|
Common Stock | 112 | — | — | 5,219 |
| 2025-07-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 297 | $139.95 | $41,565 | 70,494 |
| 2025-07-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 458 | $139.20 | $63,755 | 70,791 |
| 2025-07-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 495 | $141.28 | $69,934 | 71,249 |
| 2025-07-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 1,250 |
| 2025-07-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 71,744 |
| 2025-07-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 920 | $139.58 | $128,415 | 70,494 |
| 2025-07-21 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 291 | $139.29 | $40,533 | 128,265 |
| 2025-07-21 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 464 | $139.29 | $64,631 | 204,158 |
| 2025-07-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 602 | $139.29 | $83,853 | 71,414 |
| 2025-07-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 856 | $0.00 | $0 | 1,712 |
| 2025-07-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 856 | — | — | 204,622 |
| 2025-07-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,522 | $0.00 | $0 | 3,044 |
| 2025-07-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,522 | — | — | 72,016 |
| 2025-07-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,070 | $149.96 | $460,388 | 245,704 |
| 2025-07-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 189 | $161.29 | $30,483 | 35,782 |
| 2025-07-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,011 | $160.11 | $161,869 | 35,971 |
| 2025-07-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 300 | $159.14 | $47,742 | 36,982 |
| 2025-07-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 208 | $161.23 | $33,535 | 35,782 |
| 2025-07-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,092 | $160.10 | $174,835 | 35,990 |
| 2025-07-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $159.22 | $31,845 | 37,082 |
| 2025-07-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 648 | $167.77 | $108,714 | 173,728 |
| 2025-07-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stck | 3,187 | $167.19 | $532,839 | 174,376 |
| 2025-07-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 500 | $165.83 | $82,917 | 177,563 |
| 2025-07-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,008 | $164.00 | $165,308 | 178,063 |
| 2025-06-27 | Chapman Rowan E | — |
Equity grant / award
A
|
Common Stock | 271 | — | — | 8,616 |
| 2025-06-27 | Chapman Rowan E | — |
Equity grant / award
A
|
Common Stock | 2,143 | — | — | 8,345 |
| 2025-06-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 2,278 | $171.50 | $390,671 | 203,766 |
| 2025-06-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 7,630 | $170.63 | $1,301,911 | 206,044 |
| 2025-06-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,070 | $167.29 | $513,571 | 248,774 |
| 2025-06-18 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 10,000 | $170.18 | $1,701,795 | 213,674 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 699 | $165.41 | $115,620 | 37,282 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 425 | $164.64 | $69,972 | 37,981 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 176 | $162.52 | $28,603 | 38,606 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 547 | $165.48 | $90,519 | 37,282 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 550 | $164.81 | $90,644 | 37,829 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 203 | $163.41 | $33,172 | 38,379 |
| 2025-06-16 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $163.10 | $32,620 | 38,406 |
| 2025-06-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 5,000 | $165.85 | $829,250 | 30,000 |
| 2025-06-10 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 600 | $165.04 | $99,027 | 5,704 |
| 2025-06-10 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 3,400 | $164.33 | $558,734 | 6,304 |
| 2025-06-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 100 | $159.12 | $15,912 | 133,205 |
| 2025-06-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 465 | $158.37 | $73,643 | 133,305 |
| 2025-06-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,145 | $157.23 | $180,028 | 133,770 |
| 2025-06-02 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,290 | $156.30 | $201,629 | 134,915 |
| 2025-05-28 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 10,000 | $161.00 | $1,610,000 | 35,000 |
| 2025-05-27 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,649 | $156.85 | $258,646 | 128,556 |
| 2025-05-20 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 10,000 | $153.90 | $1,539,000 | 45,000 |
| 2025-05-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 9,000 | $153.10 | $1,377,900 | 55,000 |
| 2025-05-16 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 10,000 | $152.60 | $1,526,000 | 64,000 |
| 2025-05-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 10,000 | $150.20 | $1,502,000 | 74,000 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 708 | $159.01 | $112,577 | 38,782 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 383 | $158.01 | $60,517 | 39,490 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 409 | $157.08 | $64,248 | 39,873 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $159.77 | $15,977 | 38,782 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 690 | $159.06 | $109,749 | 38,882 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 307 | $157.88 | $48,469 | 39,572 |
| 2025-05-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 403 | $156.90 | $63,229 | 39,879 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $164.03 | $16,403 | 251,844 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 400 | $163.07 | $65,229 | 251,944 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,231 | $162.31 | $199,800 | 252,344 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 600 | $159.76 | $95,859 | 253,575 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 107 | $158.02 | $16,908 | 254,175 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 240 | $155.50 | $37,320 | 254,282 |
| 2025-05-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 392 | $153.95 | $60,348 | 254,522 |
| 2025-05-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 770 | $152.04 | $117,071 | 185,182 |
| 2025-05-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,186 | $151.26 | $330,665 | 185,952 |
| 2025-05-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,015 | $149.94 | $302,130 | 188,138 |
| 2025-05-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,009 | $148.25 | $297,837 | 190,153 |
| 2025-04-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 439 | $152.18 | $66,808 | 254,914 |
| 2025-04-25 | ROSENMAN HERM | — |
Equity grant / award
A
|
Common Stock | 164 | — | — | 66,062 |
| 2025-04-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 194 | $152.46 | $29,577 | 75,557 |
| 2025-04-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 561 | $152.45 | $85,524 | 75,751 |
| 2025-04-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 495 | $150.74 | $74,616 | 76,312 |
| 2025-04-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 2,500 |
| 2025-04-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 76,807 |
| 2025-04-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 603 | $145.35 | $87,645 | 75,557 |
| 2025-04-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 308 | $144.30 | $44,446 | 76,160 |
| 2025-04-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 8 | $146.16 | $1,169 | 76,468 |
| 2025-04-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 602 | $145.54 | $87,615 | 76,476 |
| 2025-04-21 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Open-market sell
S
|
Common Stock | 4 | $146.10 | $584 | 156,946 |
| 2025-04-21 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Open-market sell
S
|
Common Stock | 339 | $145.54 | $49,338 | 156,950 |
| 2025-04-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,521 | $0.00 | $0 | 4,566 |
| 2025-04-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,521 | — | — | 77,078 |
| 2025-04-04 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $136.05 | $13,605 | 255,249 |
| 2025-04-04 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 300 | $135.24 | $40,573 | 255,349 |
| 2025-04-04 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 400 | $133.86 | $53,544 | 255,649 |
| 2025-04-04 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,050 | $133.28 | $139,939 | 256,049 |
| 2025-04-04 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,220 | $132.04 | $161,091 | 257,099 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 355 | $140.94 | $50,034 | 40,282 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 395 | $140.00 | $55,301 | 40,637 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 490 | $138.55 | $67,889 | 41,032 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 260 | $137.08 | $35,641 | 41,522 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $141.28 | $14,128 | 40,282 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 287 | $140.57 | $40,343 | 40,382 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 396 | $139.56 | $55,265 | 40,669 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 477 | $138.57 | $66,097 | 41,065 |
| 2025-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 240 | $136.99 | $32,876 | 41,542 |
| 2025-04-01 | Marcus Gail Boxer | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,870 | $0.00 | $0 | 8,299 |
| 2025-04-01 | Marcus Gail Boxer | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,130 | $0.00 | $0 | 0 |
| 2025-04-01 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 197 | $142.82 | $28,136 | 9,704 |
| 2025-04-01 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 365 | $142.25 | $51,923 | 9,901 |
| 2025-04-01 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 1,528 | $141.13 | $215,644 | 10,266 |
| 2025-04-01 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 1,512 | $140.17 | $211,944 | 11,794 |
| 2025-04-01 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 398 | $139.33 | $55,455 | 13,306 |
| 2025-04-01 | Marcus Gail Boxer | — |
Exercise / conversion
M
|
Common Stock | 2,870 | $24.42 | $70,085 | 13,704 |
| 2025-04-01 | Marcus Gail Boxer | — |
Exercise / conversion
M
|
Common Stock | 1,130 | $7.86 | $8,882 | 10,834 |
| 2025-03-31 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 68 | $138.36 | $9,408 | 75,557 |
| 2025-03-31 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 2,494 | $138.41 | $345,195 | 75,625 |
| 2025-03-28 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 6,250 | $0.00 | $0 | 6,250 |
| 2025-03-28 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 6,250 | — | — | 78,119 |
| 2025-03-17 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 6,702 | $146.03 | $978,678 | 203,354 |
| 2025-03-12 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Equity grant / award
A
|
Common Stock | 2,032 | — | — | 72,661 |
| 2025-03-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 400 | $144.97 | $57,988 | 143,768 |
| 2025-03-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,700 | $144.12 | $245,009 | 144,168 |
| 2025-03-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 2,700 | $143.05 | $386,239 | 145,868 |
| 2025-03-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,200 | $142.08 | $170,499 | 148,568 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 96 | $162.64 | $15,613 | 43,282 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 744 | $160.85 | $119,674 | 43,674 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 292 | $158.88 | $46,394 | 44,418 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 72 | $155.66 | $11,208 | 44,710 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 100 | $162.64 | $16,264 | 43,282 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 336 | $161.58 | $54,290 | 43,382 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 704 | $160.76 | $113,173 | 43,718 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 296 | $161.64 | $47,846 | 43,378 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 64 | $155.66 | $9,962 | 44,718 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 590 | $162.06 | $95,617 | 260,789 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,280 | $161.04 | $206,126 | 261,379 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 580 | $159.24 | $92,361 | 262,659 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 200 | $157.80 | $31,560 | 263,239 |
| 2025-02-26 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 50 | $155.81 | $7,790 | 263,439 |
| 2025-02-06 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,632 | $177.77 | $290,121 | 149,768 |
| 2025-02-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 1,522 | — | — | 151,400 |
| 2025-02-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 1,675 | — | — | 149,878 |
| 2025-01-31 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,886 | $176.60 | $333,068 | 101,811 |
| 2025-01-31 | Chapman Steven Leonard | CEO AND PRESIDENT |
Equity grant / award
A
|
Common Stock | 36,682 | — | — | 290,626 |
| 2025-01-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 2 | $167.08 | $334 | 103,697 |
| 2025-01-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 3,115 | $165.87 | $516,681 | 103,699 |
| 2025-01-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1 | $167.08 | $167 | 106,814 |
| 2025-01-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,217 | $165.87 | $201,862 | 106,815 |
| 2025-01-27 | Sheena Jonathan | — |
Equity grant / award
G
|
Common Stock | 588 | $0.00 | $0 | 261,157 |
| 2025-01-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 259 | $172.44 | $44,662 | 109,474 |
| 2025-01-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 687 | $171.80 | $118,027 | 109,733 |
| 2025-01-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 495 | $171.09 | $84,690 | 110,420 |
| 2025-01-22 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 7 | $171.91 | $1,203 | 261,745 |
| 2025-01-22 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 964 | $164.95 | $159,011 | 261,752 |
| 2025-01-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 3,750 |
| 2025-01-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 110,915 |
| 2025-01-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 144 | $0.00 | $0 | 0 |
| 2025-01-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 144 | — | — | 262,716 |
| 2025-01-20 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 191 | $0.00 | $0 | 761 |
| 2025-01-20 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 191 | — | — | 262,572 |
| 2025-01-16 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,043 | $0.00 | $0 | 0 |
| 2025-01-16 | Sheena Jonathan | — |
Equity grant / award
A
|
Common Stock | 4,966 | — | — | 262,381 |
| 2025-01-16 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 3,043 | — | — | 257,415 |
| 2025-01-08 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 6,223 | $175.30 | $1,090,901 | 199,804 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 288 | $160.70 | $46,281 | 44,782 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 732 | $159.76 | $116,947 | 45,070 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 480 | $158.73 | $76,192 | 45,802 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 304 | $160.68 | $48,848 | 44,782 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 555 | $159.69 | $88,628 | 45,086 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 641 | $158.74 | $101,749 | 45,641 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 570 | $160.67 | $91,581 | 254,372 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 900 | $159.65 | $143,688 | 254,942 |
| 2025-01-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,230 | $158.71 | $195,212 | 255,842 |
| 2024-12-23 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
G
|
Common Stock | 81 | $0.00 | $0 | 114,706 |
| 2024-12-23 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Open-market sell
S
|
Common Stock | 668 | $159.60 | $106,616 | 114,142 |
| 2024-12-23 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Open-market sell
S
|
Common Stock | 1 | $157.95 | $158 | 114,810 |
| 2024-12-20 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Equity grant / award
A
|
Common Stock | 1,675 | — | — | 114,811 |
| 2024-12-19 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
G
|
Common Stock | 125 | $0.00 | $0 | 114,787 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 496 | $168.02 | $83,339 | 46,282 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Srock | 852 | $167.07 | $142,347 | 46,778 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 152 | $166.01 | $25,233 | 47,630 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 303 | $168.04 | $50,917 | 46,282 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 959 | $167.18 | $160,325 | 46,585 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 238 | $166.18 | $39,550 | 47,544 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 537 | $168.15 | $90,294 | 257,072 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,825 | $167.25 | $305,231 | 257,609 |
| 2024-12-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 338 | $165.97 | $56,099 | 259,434 |
| 2024-12-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 5,300 | $168.35 | $892,280 | 2,389,180 |
| 2024-12-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 4,927 | $167.39 | $824,722 | 2,394,480 |
| 2024-12-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 45,769 | $166.45 | $7,618,346 | 2,399,407 |
| 2024-12-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 75,323 | $165.45 | $12,462,190 | 2,445,176 |
| 2024-12-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 28,681 | $164.61 | $4,721,211 | 2,520,499 |
| 2024-12-10 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 1,767 | $170.24 | $300,808 | 6,202 |
| 2024-12-09 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,323 | $0.00 | $0 | 0 |
| 2024-12-09 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,752 | $0.00 | $0 | 0 |
| 2024-12-09 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 4,858 | $166.59 | $809,312 | 114,912 |
| 2024-12-09 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 3,323 | $12.85 | $42,701 | 119,770 |
| 2024-12-09 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 5,752 | $7.45 | $42,847 | 116,447 |
| 2024-12-05 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 68,496 | $0.00 | $0 | 0 |
| 2024-12-05 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 68,496 | $5.40 | $369,556 | 2,549,180 |
| 2024-12-02 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 11,219 | $170.54 | $1,913,298 | 1,224,787 |
| 2024-12-02 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 40,171 | $169.78 | $6,820,228 | 1,236,006 |
| 2024-12-02 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 16,853 | $168.73 | $2,843,578 | 1,276,177 |
| 2024-12-02 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 10,447 | $167.59 | $1,750,792 | 1,293,030 |
| 2024-12-02 | BOTHA ROELOF | Dir |
Open-market sell
S
|
Common Stock | 8,783 | $166.88 | $1,465,667 | 1,303,477 |
| 2024-11-26 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 400 | $165.55 | $66,220 | 84,000 |
| 2024-11-26 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 940 | $164.24 | $154,384 | 84,400 |
| 2024-11-26 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 660 | $163.25 | $107,744 | 85,340 |
| 2024-11-25 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 311 | $169.94 | $52,851 | 86,000 |
| 2024-11-25 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 600 | $168.91 | $101,346 | 86,311 |
| 2024-11-25 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 1,089 | $167.89 | $182,831 | 86,911 |
| 2024-11-19 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 2,100 | $160.52 | $337,089 | 9,704 |
| 2024-11-19 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 7,582 | $159.83 | $1,211,842 | 11,804 |
| 2024-11-15 | Baynes Roy D. | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 15,230 | $0.00 | $0 | 0 |
| 2024-11-15 | Baynes Roy D. | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 22,000 | $0.00 | $0 | 0 |
| 2024-11-15 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,983 | $149.98 | $297,408 | 15,807 |
| 2024-11-15 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 2,106 | $148.74 | $313,250 | 17,790 |
| 2024-11-15 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 9,467 | $147.31 | $1,394,620 | 19,896 |
| 2024-11-15 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 1,770 | $146.25 | $258,871 | 29,363 |
| 2024-11-15 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 16,404 | $145.21 | $2,381,997 | 31,133 |
| 2024-11-15 | Baynes Roy D. | — |
Open-market sell
S
|
Common Stock | 5,500 | $144.26 | $793,419 | 47,537 |
| 2024-11-15 | Baynes Roy D. | — |
Exercise / conversion
M
|
Common Stock | 15,230 | $24.42 | $371,917 | 53,037 |
| 2024-11-15 | Baynes Roy D. | — |
Exercise / conversion
M
|
Common Stock | 22,000 | $22.83 | $502,260 | 37,807 |
| 2024-11-14 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 200 | $162.04 | $32,408 | 19,386 |
| 2024-11-14 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 371 | $159.85 | $59,306 | 19,586 |
| 2024-11-14 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 350 | $159.19 | $55,716 | 19,957 |
| 2024-11-14 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 791 | $157.86 | $124,865 | 20,307 |
| 2024-11-14 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 500 | $156.75 | $78,377 | 21,098 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 458 | $154.40 | $70,715 | 51,857 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,617 | $152.93 | $553,134 | 52,315 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 4,075 | $160.02 | $652,065 | 47,782 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 64 | $153.51 | $9,825 | 51,857 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 4,011 | $152.78 | $612,806 | 51,921 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 11,974 | $154.11 | $1,845,296 | 259,772 |
| 2024-11-13 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 8,026 | $152.69 | $1,225,472 | 271,746 |
| 2024-11-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 10,000 | $0.00 | $0 | 68,496 |
| 2024-11-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 10,000 | $5.40 | $53,953 | 2,480,684 |
| 2024-11-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 130,000 | $0.00 | $0 | 78,496 |
| 2024-11-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 130,000 | $5.40 | $701,389 | 2,470,684 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 90 | $131.84 | $11,866 | 55,932 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 412 | $131.24 | $54,070 | 56,022 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 998 | $130.47 | $130,210 | 56,434 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 764 | $131.14 | $100,189 | 55,932 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 736 | $130.40 | $95,971 | 56,696 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 169 | $131.85 | $22,283 | 279,772 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,171 | $130.89 | $284,162 | 279,941 |
| 2024-11-08 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 360 | $129.78 | $46,720 | 282,112 |
| 2024-10-31 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,866 | $126.45 | $235,956 | 68,851 |
| 2024-10-28 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,057 | $118.21 | $124,948 | 206,027 |
| 2024-10-25 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 691 | $118.81 | $82,098 | 72,709 |
| 2024-10-25 | ROSENMAN HERM | — |
Equity grant / award
A
|
Common Stock | 178 | — | — | 65,765 |
| 2024-10-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 914 | $119.19 | $108,940 | 73,400 |
| 2024-10-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 496 | $119.09 | $59,068 | 74,314 |
| 2024-10-22 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 256 | $120.07 | $30,738 | 111,891 |
| 2024-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 5,000 |
| 2024-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 74,810 |
| 2024-10-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 143 | $0.00 | $0 | 144 |
| 2024-10-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 143 | — | — | 282,374 |
| 2024-10-21 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 294 | $120.76 | $35,503 | 112,147 |
| 2024-10-20 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 190 | $0.00 | $0 | 952 |
| 2024-10-20 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 190 | — | — | 282,231 |
| 2024-10-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 4,523 | $130.40 | $589,797 | 191,163 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,025 | $125.95 | $129,100 | 57,432 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 475 | $124.89 | $59,322 | 58,457 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 729 | $126.27 | $92,051 | 57,432 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 771 | $125.23 | $96,550 | 58,161 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 427 | $126.42 | $53,982 | 282,041 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,397 | $125.83 | $175,785 | 282,468 |
| 2024-10-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 876 | $124.82 | $109,346 | 283,865 |
| 2024-09-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,066 | $128.07 | $392,677 | 58,932 |
| 2024-09-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 6,584 | $127.39 | $838,704 | 61,998 |
| 2024-09-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,246 | $128.06 | $415,678 | 58,932 |
| 2024-09-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 6,404 | $127.38 | $815,728 | 62,178 |
| 2024-09-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 778 | $128.06 | $99,628 | 284,741 |
| 2024-09-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,922 | $127.38 | $244,822 | 285,519 |
| 2024-09-16 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 500 | $130.93 | $65,466 | 195,686 |
| 2024-09-16 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 598 | $129.90 | $77,678 | 196,186 |
| 2024-09-16 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,626 | $128.87 | $209,539 | 196,784 |
| 2024-09-16 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,258 | $127.83 | $160,807 | 198,410 |
| 2024-09-16 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,042 | $126.66 | $131,984 | 199,668 |
| 2024-09-13 | Chapman Rowan E | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,614 | $0.00 | $0 | 0 |
| 2024-09-13 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 2,614 | $127.68 | $333,756 | 7,969 |
| 2024-09-13 | Chapman Rowan E | — |
Exercise / conversion
M
|
Common Stock | 2,614 | $94.14 | $246,082 | 10,583 |
| 2024-08-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 577 | $120.00 | $69,240 | 200,710 |
| 2024-08-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 5,006 | $118.79 | $594,655 | 201,287 |
| 2024-08-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 220 | $115.70 | $25,454 | 299,441 |
| 2024-08-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 480 | $115.07 | $55,234 | 299,661 |
| 2024-08-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 781 | $114.11 | $89,119 | 300,141 |
| 2024-08-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,219 | $112.80 | $137,507 | 300,922 |
| 2024-08-08 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 190,000 | $0.00 | $0 | 208,496 |
| 2024-08-08 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 190,000 | $5.40 | $1,025,107 | 1,480,648 |
| 2024-07-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,057 | $102.77 | $108,623 | 206,400 |
| 2024-07-26 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 751 | $102.18 | $76,737 | 75,059 |
| 2024-07-26 | ROSENMAN HERM | — |
Equity grant / award
A
|
Common Stock | 206 | — | — | 65,587 |
| 2024-07-25 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 690 | $105.29 | $72,650 | 75,810 |
| 2024-07-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 918 | $105.53 | $96,877 | 76,500 |
| 2024-07-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 499 | $107.40 | $53,592 | 77,418 |
| 2024-07-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 6,250 |
| 2024-07-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,059 | $105.16 | $111,364 | 77,917 |
| 2024-07-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 78,976 |
| 2024-07-22 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 549 | $105.16 | $57,733 | 113,637 |
| 2024-07-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,145 | $0.00 | $0 | 2,290 |
| 2024-07-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,145 | — | — | 77,726 |
| 2024-07-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,522 | $0.00 | $0 | 9,131 |
| 2024-07-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,522 | — | — | 76,581 |
| 2024-07-01 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 2,723 | $108.37 | $295,080 | 206,772 |
| 2024-07-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 907 | $109.33 | $99,163 | 301,808 |
| 2024-07-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,793 | $108.63 | $194,781 | 302,715 |
| 2024-06-28 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 5,000 | $0.00 | $0 | 5,000 |
| 2024-06-28 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 5,000 | — | — | 209,495 |
| 2024-06-18 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,700 | $109.66 | $296,080 | 304,508 |
| 2024-06-17 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,247 | $112.55 | $140,350 | 213,351 |
| 2024-06-17 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,243 | $111.88 | $362,811 | 214,598 |
| 2024-06-17 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,615 | $110.35 | $178,211 | 217,841 |
| 2024-05-30 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 2,000 | $110.17 | $220,330 | 18,634 |
| 2024-05-28 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 1,647 | $109.96 | $181,103 | 114,186 |
| 2024-05-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 236 | $108.91 | $25,704 | 68,582 |
| 2024-05-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 264 | $107.77 | $28,450 | 68,818 |
| 2024-05-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 156 | $109.16 | $17,029 | 68,582 |
| 2024-05-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 344 | $107.90 | $37,118 | 68,738 |
| 2024-05-16 | Sheena Jonathan | — |
Equity grant / award
G
|
Common Stock | 11,853 | $0.00 | $0 | 307,208 |
| 2024-05-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,320 | $107.59 | $357,201 | 219,456 |
| 2024-05-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,459 | $106.59 | $368,710 | 222,776 |
| 2024-05-10 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 30,000 | $0.00 | $0 | 12,500 |
| 2024-05-10 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 10,350 | $108.09 | $1,118,783 | 204,495 |
| 2024-05-10 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 4,255 | $104.03 | $442,634 | 214,845 |
| 2024-05-10 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 9,398 | $102.91 | $967,152 | 219,100 |
| 2024-05-10 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 5,997 | $101.55 | $608,998 | 228,498 |
| 2024-05-10 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 30,000 | $19.68 | $590,400 | 234,495 |
| 2024-05-08 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 215,000 | $0.00 | $0 | 398,496 |
| 2024-05-08 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 215,000 | $5.40 | $1,159,990 | 1,290,648 |
| 2024-05-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 200 | $95.64 | $19,128 | 67,542 |
| 2024-05-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 866 | $93.88 | $81,299 | 68,142 |
| 2024-05-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 400 | $94.70 | $37,879 | 67,742 |
| 2024-04-29 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Open-market sell
S
|
Common Stock | 929 | $93.14 | $86,526 | 110,748 |
| 2024-04-26 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 751 | $92.00 | $69,092 | 70,646 |
| 2024-04-26 | HEALY JAMES | — |
Equity grant / award
A
|
Common Stock | 210 | — | — | 42,710 |
| 2024-04-25 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 705 | $89.55 | $63,133 | 71,397 |
| 2024-04-25 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 500 | $89.55 | $44,775 | 69,082 |
| 2024-04-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 937 | $93.00 | $87,140 | 72,102 |
| 2024-04-23 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 531 | $91.38 | $48,522 | 117,029 |
| 2024-04-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 143 | $0.00 | $0 | 430 |
| 2024-04-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 143 | — | — | 321,364 |
| 2024-04-20 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 190 | $0.00 | $0 | 1,332 |
| 2024-04-20 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 190 | — | — | 321,221 |
| 2024-04-16 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 53,489 | $91.06 | $4,870,730 | 117,560 |
| 2024-04-16 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 26,511 | $90.34 | $2,394,922 | 171,049 |
| 2024-04-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 100 | $94.44 | $9,444 | 227,710 |
| 2024-04-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,411 | $93.91 | $226,417 | 227,810 |
| 2024-04-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 4,305 | $92.67 | $398,937 | 230,221 |
| 2024-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 7,863 | $93.37 | $734,140 | 321,031 |
| 2024-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 10,138 | $92.57 | $938,478 | 328,894 |
| 2024-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 8,699 | $91.53 | $796,204 | 339,032 |
| 2024-04-02 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,378 | $92.62 | $127,629 | 70,646 |
| 2024-03-28 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,662 | $90.42 | $240,687 | 234,526 |
| 2024-03-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 500 | $90.13 | $45,065 | 69,582 |
| 2024-03-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 313 | $90.13 | $28,211 | 347,731 |
| 2024-03-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 134 | $90.42 | $12,116 | 348,044 |
| 2024-03-28 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 707 | $90.42 | $63,924 | 197,560 |
| 2024-03-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 5,184 | $0.00 | $0 | 0 |
| 2024-03-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 5,184 | — | — | 237,188 |
| 2024-03-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 447 | $0.00 | $0 | 0 |
| 2024-03-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 447 | — | — | 348,178 |
| 2024-03-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 20,070 | $89.60 | $1,798,370 | 0 |
| 2024-03-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 20,575 | $88.97 | $1,830,574 | 20,070 |
| 2024-03-15 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 10,265 | $87.98 | $903,121 | 40,645 |
| 2024-03-07 | Sheena Jonathan | — |
Equity grant / award
G
|
Common Stock | 55,427 | $0.00 | $0 | 70,082 |
| 2024-03-07 | Sheena Jonathan | — |
Equity grant / award
G
|
Common Stock | 110,854 | $0.00 | $0 | 347,731 |
| 2024-03-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,816 | $89.13 | $161,857 | 458,585 |
| 2024-03-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,184 | $88.45 | $281,635 | 460,401 |
| 2024-03-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 2,227 | $88.36 | $196,789 | 198,267 |
| 2024-03-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 18 | $87.33 | $1,572 | 200,494 |
| 2024-03-05 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,028 | $88.36 | $90,839 | 463,585 |
| 2024-03-01 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Equity grant / award
A
|
Common Stock | 4,104 | — | — | 1,076,660 |
| 2024-02-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 20,526 | $0.00 | $0 | 0 |
| 2024-02-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 14,426 | $89.72 | $1,294,351 | 204,218 |
| 2024-02-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 3,400 | $87.87 | $298,765 | 218,644 |
| 2024-02-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 2,600 | $86.67 | $225,344 | 222,044 |
| 2024-02-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 100 | $85.10 | $8,510 | 224,644 |
| 2024-02-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 20,526 | $9.29 | $190,687 | 224,744 |
| 2024-02-29 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 3,206 | — | — | 200,512 |
| 2024-02-27 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 7,807 | $0.00 | $0 | 20,526 |
| 2024-02-27 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 27,500 | $0.00 | $0 | 0 |
| 2024-02-27 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 35,307 | $75.09 | $2,651,298 | 204,218 |
| 2024-02-27 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 7,807 | $9.29 | $72,527 | 239,525 |
| 2024-02-27 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 27,500 | $10.41 | $286,275 | 231,718 |
| 2024-02-23 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 380,036 | $0.00 | $0 | 0 |
| 2024-02-23 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 380,036 | $2.66 | $1,009,718 | 1,050,036 |
| 2024-02-16 | ROSENMAN HERM | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 93,901 | $0.00 | $0 | 0 |
| 2024-02-16 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 35,947 | $69.85 | $2,510,851 | 61,685 |
| 2024-02-16 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 57,954 | $69.08 | $4,003,520 | 97,632 |
| 2024-02-16 | ROSENMAN HERM | — |
Exercise / conversion
M
|
Common Stock | 93,901 | $2.66 | $249,486 | 155,586 |
| 2024-02-06 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 23,959 | $0.00 | $0 | 0 |
| 2024-02-06 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 10,070 | $0.00 | $0 | 0 |
| 2024-02-06 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 34,029 | $70.03 | $2,383,129 | 70,646 |
| 2024-02-06 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 23,959 | $19.68 | $471,513 | 104,675 |
| 2024-02-06 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 10,070 | $9.29 | $93,550 | 80,716 |
| 2024-02-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 22,281 | $67.73 | $1,509,081 | 70,646 |
| 2024-01-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 3,235 | $65.09 | $210,570 | 92,927 |
| 2024-01-29 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Open-market sell
S
|
Common Stock | 3,426 | $65.09 | $223,002 | 194,977 |
| 2024-01-26 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Equity grant / award
A
|
Common Stock | 68,976 | — | — | 1,072,556 |
| 2024-01-26 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Equity grant / award
A
|
Common Stock | 31,352 | — | — | 96,162 |
| 2024-01-26 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Equity grant / award
A
|
Common Stock | 31,352 | — | — | 198,403 |
| 2024-01-24 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 944 | $67.00 | $63,248 | 64,810 |
| 2024-01-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,896 | $65.70 | $124,570 | 65,754 |
| 2024-01-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 306 | $66.81 | $20,444 | 67,650 |
| 2024-01-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 8,750 |
| 2024-01-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 771 | $68.16 | $52,551 | 67,956 |
| 2024-01-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 68,727 |
| 2024-01-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,145 | $0.00 | $0 | 4,580 |
| 2024-01-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,145 | — | — | 67,477 |
| 2024-01-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,522 | $0.00 | $0 | 12,174 |
| 2024-01-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,522 | — | — | 66,332 |
| 2024-01-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 40 | $60.91 | $2,437 | 21,155 |
| 2024-01-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 460 | $60.42 | $27,795 | 21,195 |
| 2024-01-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 500 | $60.44 | $30,219 | 21,155 |
| 2024-01-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,345 | $60.67 | $142,264 | 469,743 |
| 2024-01-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,655 | $59.98 | $159,235 | 472,088 |
| 2023-12-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,377 | $62.29 | $85,773 | 64,810 |
| 2023-12-28 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 915 | $63.29 | $57,912 | 66,187 |
| 2023-12-27 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,292 | $0.00 | $0 | 2,292 |
| 2023-12-27 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 2,292 | — | — | 67,102 |
| 2023-12-13 | HEALY JAMES | Dir |
Open-market sell
S
|
Common Stock | 644,000 | $58.75 | $37,835,000 | 0 |
| 2023-12-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Equity grant / award
G · derivative
|
Stock Option (right to buy) | 380,036 | $0.00 | $0 | 380,036 |
| 2023-12-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Equity grant / award
G
|
Common Stock | 250,000 | $0.00 | $0 | 1,003,580 |
| 2023-12-08 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 500 | $57.52 | $28,760 | 20,146 |
| 2023-12-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 400 | $58.88 | $23,552 | 474,743 |
| 2023-12-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 4,600 | $58.16 | $267,526 | 475,143 |
| 2023-11-29 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 1,998 | $55.97 | $111,831 | 9,373 |
| 2023-11-21 | Marcus Gail Boxer | — |
Open-market sell
S
|
Common Stock | 1,000 | $54.31 | $54,314 | 20,646 |
| 2023-11-20 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,566 | $55.00 | $141,130 | 217,554 |
| 2023-11-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 500 | $40.23 | $20,115 | 22,155 |
| 2023-11-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 5,000 | $40.23 | $201,150 | 479,743 |
| 2023-10-27 | Williams Brinkley Ruth | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 515 | $25.03 | $12,890 | 515 |
| 2023-10-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 203 | $40.90 | $8,302 | 64,810 |
| 2023-10-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 2,172 | $40.37 | $87,682 | 65,013 |
| 2023-10-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,565 | $40.39 | $63,211 | 67,185 |
| 2023-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,250 | $0.00 | $0 | 10,000 |
| 2023-10-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,250 | — | — | 68,750 |
| 2023-10-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,145 | $0.00 | $0 | 5,725 |
| 2023-10-21 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,145 | — | — | 67,500 |
| 2023-10-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,522 | $0.00 | $0 | 13,696 |
| 2023-10-20 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,522 | — | — | 66,355 |
| 2023-09-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,372 | $45.98 | $63,080 | 64,833 |
| 2023-09-28 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 919 | $45.82 | $42,105 | 66,205 |
| 2023-09-27 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,291 | $0.00 | $0 | 4,584 |
| 2023-09-27 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 2,291 | — | — | 67,124 |
| 2023-09-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 500 | $59.22 | $29,610 | 23,155 |
| 2023-09-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 498 | $59.59 | $29,675 | 489,746 |
| 2023-09-06 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 4,502 | $59.02 | $265,690 | 490,244 |
| 2023-09-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 10,000 | $60.01 | $600,062 | 494,746 |
| 2023-08-11 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,578 | $55.00 | $141,790 | 214,988 |
| 2023-08-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 5,000 | $44.22 | $221,116 | 504,746 |
| 2023-08-02 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 500 | $44.15 | $22,075 | 23,655 |
| 2023-07-28 | Williams Brinkley Ruth | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 428 | $29.68 | $12,703 | 428 |
| 2023-07-25 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 2,347 | $46.58 | $109,323 | 64,833 |
| 2023-07-24 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 800 | $47.83 | $38,261 | 178,478 |
| 2023-07-21 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 644 | $0.00 | $0 | 3,864 |
| 2023-07-21 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 644 | — | — | 179,278 |
| 2023-07-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 856 | $0.00 | $0 | 8,560 |
| 2023-07-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 856 | — | — | 178,634 |
| 2023-06-30 | ROSENMAN HERM | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 4,255 | $0.00 | $0 | 4,255 |
| 2023-06-30 | ROSENMAN HERM | — |
Equity grant / award
A
|
Common Stock | 2,750 | — | — | 60,548 |
| 2023-06-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,377 | $51.11 | $70,378 | 64,833 |
| 2023-06-28 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 915 | $50.88 | $46,556 | 66,210 |
| 2023-06-28 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,605 | $50.88 | $132,545 | 214,983 |
| 2023-06-27 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,292 | $0.00 | $0 | 6,875 |
| 2023-06-27 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 2,292 | — | — | 67,125 |
| 2023-06-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 5,183 | $0.00 | $0 | 15,550 |
| 2023-06-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 5,183 | — | — | 217,588 |
| 2023-06-13 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 1,767 | $50.58 | $89,366 | 8,621 |
| 2023-06-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 348 | $49.39 | $17,189 | 24,655 |
| 2023-06-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 152 | $48.41 | $7,359 | 25,003 |
| 2023-06-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 3,283 | $49.43 | $162,281 | 514,746 |
| 2023-06-07 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,717 | $48.54 | $83,346 | 518,029 |
| 2023-05-25 | HEALY JAMES | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,534 | $0.00 | $0 | 0 |
| 2023-05-25 | HEALY JAMES | — |
Exercise / conversion
M
|
Common Stock | 3,534 | — | — | 38,762 |
| 2023-05-10 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,175 | $54.50 | $118,548 | 519,746 |
| 2023-05-10 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 2,825 | $53.72 | $151,771 | 521,921 |
| 2023-04-25 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 2,364 | $50.99 | $120,550 | 64,833 |
| 2023-04-24 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 43 | $54.98 | $2,364 | 524,746 |
| 2023-04-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 143 | $0.00 | $0 | 1,002 |
| 2023-04-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 143 | — | — | 524,789 |
| 2023-04-21 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 233 | $54.22 | $12,634 | 524,646 |
| 2023-04-21 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 57 | $54.27 | $3,093 | 524,879 |
| 2023-04-20 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 190 | $0.00 | $0 | 2,093 |
| 2023-04-20 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 190 | — | — | 524,936 |
| 2023-04-14 | Williams Brinkley Ruth | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 120 | $32.88 | $3,946 | 120 |
| 2023-04-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 5,000 | $54.02 | $270,081 | 524,746 |
| 2023-03-29 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,571 | $55.00 | $141,405 | 209,819 |
| 2023-03-29 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Equity grant / award
G
|
Common Stock | 613,496 | $0.00 | $0 | 0 |
| 2023-03-28 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,612 | $55.13 | $144,002 | 212,390 |
| 2023-03-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 5,183 | $0.00 | $0 | 20,733 |
| 2023-03-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 5,183 | — | — | 215,002 |
| 2023-03-24 | Williams Brinkley Ruth | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 10,767 | $0.00 | $0 | 10,767 |
| 2023-03-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 135 | $56.08 | $7,571 | 529,433 |
| 2023-03-22 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 455 | $0.00 | $0 | 0 |
| 2023-03-22 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 455 | — | — | 529,568 |
| 2023-03-22 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,259 | $56.32 | $70,909 | 529,113 |
| 2023-03-17 | Sheena Jonathan | — |
Equity grant / award
A
|
Common Stock | 1,259 | — | — | 530,372 |
| 2023-03-02 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,377 | $56.54 | $77,859 | 175,387 |
| 2023-03-02 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 6,435 | $56.08 | $360,863 | 176,764 |
| 2023-03-02 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 1,400 | $55.02 | $77,031 | 183,199 |
| 2023-03-02 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 100 | $53.05 | $5,305 | 184,599 |
| 2023-02-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,289 | $0.00 | $0 | 0 |
| 2023-02-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 2,289 | — | — | 529,113 |
| 2023-02-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 4,152 | $44.35 | $184,152 | 49,664 |
| 2023-02-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 10,413 | $43.81 | $456,204 | 53,816 |
| 2023-02-01 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 4,761 | $42.81 | $203,796 | 64,229 |
| 2023-01-31 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 35,000 | $42.33 | $1,481,560 | 68,990 |
| 2023-01-30 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,509 | $43.14 | $65,098 | 103,990 |
| 2023-01-30 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 47,188 | $42.05 | $1,984,227 | 105,499 |
| 2023-01-27 | Chapman Steven Leonard | CEO AND PRESIDENT |
Equity grant / award
A
|
Common Stock | 127,265 | — | — | 231,044 |
| 2023-01-23 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Open-market sell
S
|
Common Stock | 2,387 | $41.56 | $99,203 | 148,853 |
| 2023-01-21 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 644 | $0.00 | $0 | 5,152 |
| 2023-01-21 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 644 | — | — | 151,240 |
| 2023-01-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,424 | $0.00 | $0 | 10,272 |
| 2023-01-20 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 3,424 | — | — | 150,596 |
| 2023-01-13 | HEALY JAMES | — |
Equity grant / award
A
|
Common Stock | 390 | $40.01 | $15,604 | 34,943 |
| 2023-01-10 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,938 | $0.00 | $0 | 38,134 |
| 2023-01-10 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,938 | $13.01 | $51,233 | 11,824 |
| 2023-01-09 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 2,244 | $37.62 | $84,419 | 7,886 |
| 2023-01-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,985 | $0.00 | $0 | 0 |
| 2023-01-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,985 | — | — | 10,130 |
| 2023-01-03 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,236 | $39.55 | $48,888 | 570,074 |
| 2022-12-31 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 4,141 | $0.00 | $0 | 0 |
| 2022-12-31 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 4,141 | — | — | 571,310 |
| 2022-12-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 134 | $39.84 | $5,339 | 567,169 |
| 2022-12-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 447 | $0.00 | $0 | 2,235 |
| 2022-12-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 447 | — | — | 567,303 |
| 2022-12-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 429 | $42.30 | $18,147 | 89,974 |
| 2022-12-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,077 | $0.00 | $0 | 1,078 |
| 2022-12-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,077 | — | — | 90,403 |
| 2022-12-07 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,146 | $0.00 | $0 | 23,949 |
| 2022-12-07 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 9,158 | $0.00 | $0 | 0 |
| 2022-12-07 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,645 | $38.31 | $101,330 | 80,985 |
| 2022-12-07 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 1,146 | $13.01 | $14,909 | 83,630 |
| 2022-12-07 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 9,158 | $9.29 | $85,078 | 82,484 |
| 2022-11-16 | HEALY JAMES | Dir |
Open-market sell
S
|
Common Stock | 2,400 | $37.71 | $90,498 | 0 |
| 2022-10-24 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 3,135 | $42.41 | $132,957 | 4,932 |
| 2022-10-22 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 5,000 | $0.00 | $0 | 15,000 |
| 2022-10-22 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 5,000 | — | — | 8,067 |
| 2022-10-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,145 | $0.00 | $0 | 10,306 |
| 2022-10-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 1,145 | — | — | 3,067 |
| 2022-10-18 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,922 | $0.00 | $0 | 42,072 |
| 2022-10-18 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 1,922 | $13.01 | $25,005 | 1,922 |
| 2022-10-14 | ROSENMAN HERM | — |
Equity grant / award
A
|
Common Stock | 399 | $45.42 | $18,123 | 53,480 |
| 2022-10-10 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 2,008 | $42.12 | $84,571 | 3,915 |
| 2022-10-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,984 | $0.00 | $0 | 3,985 |
| 2022-10-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,984 | — | — | 5,923 |
| 2022-10-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,559 | $44.43 | $69,266 | 72,457 |
| 2022-10-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 3,125 |
| 2022-10-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 74,016 |
| 2022-09-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 447 | $0.00 | $0 | 2,682 |
| 2022-09-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 447 | — | — | 566,438 |
| 2022-09-23 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,674 | $45.30 | $75,828 | 68,313 |
| 2022-09-23 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,674 | $45.30 | $75,828 | 71,438 |
| 2022-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 6,250 |
| 2022-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 182 | $0.00 | $0 | 366 |
| 2022-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 73,112 |
| 2022-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 182 | — | — | 69,987 |
| 2022-07-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 143 | $0.00 | $0 | 1,431 |
| 2022-07-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 143 | — | — | 565,536 |
| 2022-07-20 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,281 | $0.00 | $0 | 43,994 |
| 2022-07-20 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 1,281 | $13.01 | $16,666 | 4,607 |
| 2022-07-08 | Bertagnolli Monica | — |
Equity grant / award
A
|
Common Stock | 344 | $0.00 | $0 | 998 |
| 2022-07-08 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 2,019 | $39.51 | $79,778 | 3,326 |
| 2022-07-08 | ROSENMAN HERM | — |
Equity grant / award
A · derivative
|
Restricted Stock Unit | 499 | $36.31 | $18,119 | 499 |
| 2022-07-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,985 | $0.00 | $0 | 7,969 |
| 2022-07-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,985 | — | — | 5,345 |
| 2022-07-05 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,550 | $36.93 | $57,242 | 68,916 |
| 2022-07-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 6,250 |
| 2022-07-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 70,466 |
| 2022-06-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 447 | $0.00 | $0 | 3,129 |
| 2022-06-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 447 | — | — | 565,393 |
| 2022-06-22 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 455 | $0.00 | $0 | 1,365 |
| 2022-06-22 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 455 | — | — | 564,946 |
| 2022-05-27 | ROSENMAN HERM | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 7,068 | $0.00 | $0 | 7,068 |
| 2022-05-27 | ROSENMAN HERM | — |
Equity grant / award
A · derivative
|
Restricted Stock Unit | 3,534 | $0.00 | $0 | 3,534 |
| 2022-05-25 | Marcus Gail Boxer | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,614 | $0.00 | $0 | 0 |
| 2022-05-25 | Marcus Gail Boxer | — |
Exercise / conversion
M
|
Common Stock | 2,614 | — | — | 8,326 |
| 2022-05-18 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,202 | $0.00 | $0 | 45,275 |
| 2022-05-18 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,202 | $13.01 | $41,658 | 3,202 |
| 2022-05-13 | Sheena Jonathan | — |
Equity grant / award
A · derivative
|
Restricted Stock Unit | 4,141 | $0.00 | $0 | 4,141 |
| 2022-05-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market buy
P
|
Common Stock | 19,011 | $29.56 | $562,055 | 420,000 |
| 2022-05-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market buy
P
|
Common Stock | 159,783 | $28.81 | $4,603,348 | 400,989 |
| 2022-05-12 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market buy
P
|
Common Stock | 41,026 | $28.09 | $1,152,359 | 241,026 |
| 2022-04-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 143 | $0.00 | $0 | 1,574 |
| 2022-04-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 143 | — | — | 564,491 |
| 2022-04-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 307 | $0.00 | $0 | 0 |
| 2022-04-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 307 | — | — | 634,546 |
| 2022-04-08 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 1,999 | $41.91 | $83,779 | 3,352 |
| 2022-04-08 | BOTHA ROELOF | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 735 | $28.91 | $21,249 | 735 |
| 2022-04-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,984 | $0.00 | $0 | 12,056 |
| 2022-04-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,984 | — | — | 5,351 |
| 2022-04-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,559 | $43.09 | $67,177 | 62,242 |
| 2022-04-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 9,375 |
| 2022-04-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 63,801 |
| 2022-03-28 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 1,382 | $39.63 | $54,767 | 1,367 |
| 2022-03-27 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,749 | $0.00 | $0 | 21,996 |
| 2022-03-27 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 2,749 | — | — | 2,749 |
| 2022-03-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 138 | $40.60 | $5,603 | 564,035 |
| 2022-03-22 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 455 | $0.00 | $0 | 1,820 |
| 2022-03-22 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 455 | — | — | 564,173 |
| 2022-03-16 | BOTHA ROELOF | Dir |
Open-market buy
P
|
Common Stock | 40,695 | $33.49 | $1,362,798 | 1,291,584 |
| 2022-03-16 | BOTHA ROELOF | Dir |
Open-market buy
P
|
Common Stock | 85,903 | $32.59 | $2,799,983 | 1,250,889 |
| 2022-03-16 | BOTHA ROELOF | Dir |
Open-market buy
P
|
Common Stock | 26,402 | $31.92 | $842,630 | 1,164,986 |
| 2022-03-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 160,000 | $0.00 | $0 | 380,036 |
| 2022-03-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 160,000 | $2.66 | $425,104 | 678,838 |
| 2022-03-10 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,197 | $42.16 | $50,466 | 78,231 |
| 2022-03-09 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,021 | $0.00 | $0 | 0 |
| 2022-03-09 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 3,021 | — | — | 79,428 |
| 2022-03-04 | Sheena Jonathan | — |
Other disposed transaction
F
|
Common Stock | 1,088 | $58.39 | $63,528 | 540,170 |
| 2022-03-02 | Sheena Jonathan | — |
Equity grant / award
A
|
Common Stock | 3,225 | $0.00 | $0 | 541,258 |
| 2022-02-07 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 20,000 | $0.00 | $0 | 21,950 |
| 2022-02-07 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 20,000 | $1.14 | $22,820 | 544,483 |
| 2022-01-28 | Sheena Jonathan | — |
Equity grant / award
A · derivative
|
Restricted Stock Unit | 3,043 | $0.00 | $0 | 3,043 |
| 2022-01-24 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 208 | $59.95 | $12,469 | 524,483 |
| 2022-01-21 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 572 | $0.00 | $0 | 1,717 |
| 2022-01-21 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 572 | — | — | 524,691 |
| 2022-01-19 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 25,000 | $0.00 | $0 | 41,950 |
| 2022-01-19 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 25,000 | $1.14 | $28,525 | 524,119 |
| 2022-01-14 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 40,000 | $0.00 | $0 | 21,353 |
| 2022-01-14 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 40,385 | $0.00 | $0 | 0 |
| 2022-01-14 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 40,000 | $10.41 | $416,400 | 136,809 |
| 2022-01-14 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Exercise / conversion
M
|
Common Stock | 40,385 | $9.59 | $387,292 | 96,809 |
| 2022-01-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 307 | $0.00 | $0 | 307 |
| 2022-01-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 307 | — | — | 426,019 |
| 2022-01-07 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 20,000 | $0.00 | $0 | 66,950 |
| 2022-01-07 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 20,000 | $1.14 | $22,820 | 499,119 |
| 2022-01-05 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 4,995 | $82.61 | $412,637 | 51,911 |
| 2022-01-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 9,375 | $0.00 | $0 | 0 |
| 2022-01-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 9,375 | — | — | 56,906 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 18,750 | $0.00 | $0 | 0 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,084 | $0.00 | $0 | 31,250 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 4,072 | $0.00 | $0 | 25,095 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,052 | $0.00 | $0 | 9,158 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,209 | $91.52 | $110,648 | 47,531 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,310 | $90.83 | $118,985 | 48,740 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,493 | $89.29 | $133,305 | 50,050 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 10,005 | $88.44 | $884,803 | 51,543 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 12,890 | $87.82 | $1,131,977 | 61,548 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,260 | $86.22 | $194,847 | 74,438 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 18,750 | $25.46 | $477,375 | 76,698 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 2,084 | $20.27 | $42,243 | 57,948 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 4,072 | $13.01 | $52,977 | 55,864 |
| 2022-01-03 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,052 | $9.29 | $28,353 | 51,792 |
| 2022-01-03 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 20,000 | $0.00 | $0 | 86,950 |
| 2022-01-03 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 20,000 | $1.14 | $22,820 | 479,119 |
| 2022-01-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 12,500 |
| 2022-01-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 48,740 |
| 2021-12-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 202 | $91.34 | $18,451 | 459,119 |
| 2021-12-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 447 | $0.00 | $0 | 4,023 |
| 2021-12-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 447 | — | — | 459,321 |
| 2021-12-23 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 204 | $92.99 | $18,970 | 458,874 |
| 2021-12-22 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 455 | $0.00 | $0 | 2,275 |
| 2021-12-22 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 455 | — | — | 459,078 |
| 2021-12-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,000 | $0.00 | $0 | 48,477 |
| 2021-12-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 3,329 | $93.43 | $311,012 | 62,283 |
| 2021-12-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 3,671 | $92.58 | $339,848 | 65,612 |
| 2021-12-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 2,293 | $93.43 | $214,237 | 21,517 |
| 2021-12-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 2,707 | $92.59 | $250,635 | 23,810 |
| 2021-12-21 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 5,000 | $13.01 | $65,050 | 26,517 |
| 2021-12-10 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 1,196 | $91.33 | $109,231 | 65,662 |
| 2021-12-09 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,021 | $0.00 | $0 | 3,021 |
| 2021-12-09 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 3,021 | — | — | 66,858 |
| 2021-12-08 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,281 | $0.00 | $0 | 53,477 |
| 2021-12-08 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 1,281 | $13.01 | $16,666 | 21,517 |
| 2021-12-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 4,411 | $91.99 | $405,777 | 20,236 |
| 2021-12-04 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 8,750 | $0.00 | $0 | 0 |
| 2021-12-04 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 8,750 | — | — | 24,647 |
| 2021-12-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,083 | $0.00 | $0 | 33,334 |
| 2021-12-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,053 | $0.00 | $0 | 12,210 |
| 2021-12-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,904 | $91.09 | $355,629 | 35,586 |
| 2021-12-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,315 | $90.45 | $299,826 | 39,490 |
| 2021-12-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 2,083 | $20.27 | $42,222 | 42,805 |
| 2021-12-01 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,053 | $9.29 | $28,362 | 38,639 |
| 2021-11-17 | Bertagnolli Monica | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 654 | $0.00 | $0 | 1,306 |
| 2021-11-17 | Bertagnolli Monica | — |
Exercise / conversion
M
|
Common Stock | 654 | — | — | 654 |
| 2021-11-10 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stook | 895 | $112.62 | $100,797 | 58,588 |
| 2021-11-10 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stoock | 2,422 | $112.03 | $271,330 | 59,483 |
| 2021-11-10 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 22,178 | $110.98 | $2,461,294 | 61,905 |
| 2021-11-08 | ROSENMAN HERM | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 44,503 | $0.00 | $0 | 93,901 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 400 | $120.24 | $48,096 | 51,275 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 2,832 | $119.62 | $338,758 | 51,675 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 2,100 | $118.79 | $249,455 | 54,507 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 39,171 | $17.13 | $670,893 | 56,607 |
| 2021-11-08 | ROSENMAN HERM | — |
Exercise / conversion
M
|
Common Stock | 44,503 | $2.66 | $118,240 | 95,778 |
| 2021-11-08 | ROSENMAN HERM | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 44,503 | $0.00 | $0 | 93,901 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 400 | $120.24 | $48,096 | 51,275 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 2,832 | $119.62 | $338,758 | 51,675 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 2,100 | $118.79 | $249,455 | 54,507 |
| 2021-11-08 | ROSENMAN HERM | — |
Open-market sell
S
|
Common Stock | 39,171 | $117.13 | $4,587,993 | 56,607 |
| 2021-11-08 | ROSENMAN HERM | — |
Exercise / conversion
M
|
Common Stock | 44,503 | $2.66 | $118,240 | 95,778 |
| 2021-11-01 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 6,000 | $0.00 | $0 | 54,758 |
| 2021-11-01 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 6,000 | $120.00 | $720,010 | 15,897 |
| 2021-11-01 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 6,000 | $13.01 | $78,060 | 27,897 |
| 2021-10-22 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Equity grant / award
A · derivative
|
Restricted Stock Unit | 10,000 | $0.00 | $0 | 10,000 |
| 2021-10-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 122 | $112.19 | $13,687 | 582,494 |
| 2021-10-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 307 | $0.00 | $0 | 614 |
| 2021-10-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 307 | — | — | 582,616 |
| 2021-10-12 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,281 | $0.00 | $0 | 60,758 |
| 2021-10-12 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 1,281 | $13.01 | $16,666 | 23,178 |
| 2021-10-08 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 1,986 | $117.08 | $232,521 | 25,213 |
| 2021-10-08 | BOTHA ROELOF | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 252 | $74.31 | $18,726 | 252 |
| 2021-10-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,984 | $0.00 | $0 | 19,923 |
| 2021-10-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,984 | — | — | 27,199 |
| 2021-10-05 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,608 | $110.91 | $178,343 | 37,103 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,084 | $0.00 | $0 | 37,500 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 37 | $111.54 | $4,127 | 0 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 431 | $110.23 | $47,510 | 37 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,239 | $108.81 | $134,811 | 468 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 4,966 | $108.07 | $536,658 | 1,707 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 5,139 | $106.97 | $549,698 | 6,673 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,084 | $105.88 | $114,769 | 11,812 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 258 | $111.54 | $28,777 | 38,711 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 256 | $110.24 | $28,222 | 38,969 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,870 | $108.81 | $203,465 | 39,225 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,784 | $107.89 | $192,470 | 41,095 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 2,084 | $20.27 | $42,243 | 42,879 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 154 | $111.54 | $17,177 | 38,711 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 500 | $109.26 | $54,630 | 38,865 |
| 2021-10-04 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,831 | $108.20 | $198,122 | 39,365 |
| 2021-10-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 15,625 |
| 2021-10-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 41,196 |
| 2021-09-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 201 | $109.76 | $22,061 | 457,381 |
| 2021-09-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 8 | $108.59 | $869 | 457,582 |
| 2021-09-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 447 | $0.00 | $0 | 4,470 |
| 2021-09-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 447 | — | — | 457,590 |
| 2021-09-27 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 2,749 | — | — | 30,646 |
| 2021-09-24 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,454 | $121.52 | $298,206 | 35,586 |
| 2021-09-24 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 5,802 | $120.52 | $699,256 | 38,040 |
| 2021-09-24 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 10,125 | $118.91 | $1,204,007 | 43,842 |
| 2021-09-24 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 5,292 | $117.97 | $624,311 | 53,967 |
| 2021-09-24 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,241 | $116.69 | $378,178 | 59,259 |
| 2021-09-23 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,649 | $125.67 | $207,230 | 62,500 |
| 2021-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 18,750 |
| 2021-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 182 | $0.00 | $0 | 1,094 |
| 2021-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 64,149 |
| 2021-09-22 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 182 | — | — | 61,024 |
| 2021-09-17 | Chapman Rowan E | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,500 | $0.00 | $0 | 11,000 |
| 2021-09-17 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 4,500 | $120.93 | $544,167 | 4,856 |
| 2021-09-17 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 1,000 | $120.08 | $120,083 | 9,356 |
| 2021-09-17 | Chapman Rowan E | — |
Exercise / conversion
M
|
Common Stock | 5,500 | $32.15 | $176,825 | 10,356 |
| 2021-09-10 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,030 | $119.53 | $123,114 | 456,892 |
| 2021-09-09 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,292 | $0.00 | $0 | 4,584 |
| 2021-09-09 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 2,292 | — | — | 457,922 |
| 2021-09-02 | Cozzens Todd C | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 10,578 | $0.00 | $0 | 591 |
| 2021-09-02 | Cozzens Todd C | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 11,169 | $0.00 | $0 | 0 |
| 2021-09-02 | Cozzens Todd C | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,733 | $0.00 | $0 | 0 |
| 2021-09-02 | Cozzens Todd C | — |
Open-market sell
S
|
Common Stock | 4,764 | $122.71 | $584,570 | 23,865 |
| 2021-09-02 | Cozzens Todd C | — |
Open-market sell
S
|
Common Stock | 10,666 | $121.96 | $1,300,862 | 17,963 |
| 2021-09-02 | Cozzens Todd C | — |
Open-market sell
S
|
Common Stock | 8,841 | $120.96 | $1,069,428 | 28,629 |
| 2021-09-02 | Cozzens Todd C | — |
Exercise / conversion
M
|
Common Stock | 10,578 | $10.41 | $110,117 | 37,470 |
| 2021-09-02 | Cozzens Todd C | — |
Exercise / conversion
M
|
Common Stock | 11,169 | $11.80 | $131,794 | 26,892 |
| 2021-09-02 | Cozzens Todd C | — |
Exercise / conversion
M
|
Common Stock | 2,733 | $1.39 | $3,787 | 15,723 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,424 | $0.00 | $0 | 9,980 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 6,545 | $0.00 | $0 | 26,835 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 552 | $0.00 | $0 | 39,615 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,018 | $0.00 | $0 | 0 |
| 2021-09-01 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 13,539 | $121.12 | $1,639,873 | 455,630 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 5,424 | $9.29 | $50,389 | 469,169 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M
|
Commom Stock | 6,545 | $10.41 | $68,133 | 463,745 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 552 | $9.59 | $5,294 | 457,200 |
| 2021-09-01 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 1,018 | $5.40 | $5,492 | 456,648 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,942 | $0.00 | $0 | 15,404 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,900 | $0.00 | $0 | 33,380 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 168 | $0.00 | $0 | 40,167 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 310 | $0.00 | $0 | 1,018 |
| 2021-08-30 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 4,320 | $121.36 | $524,284 | 455,630 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 1,942 | $9.29 | $18,041 | 459,950 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 1,900 | $10.41 | $19,779 | 458,008 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 168 | $9.59 | $1,611 | 456,108 |
| 2021-08-30 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 310 | $5.40 | $1,673 | 455,940 |
| 2021-08-17 | Chapman Rowan E | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,500 | $0.00 | $0 | 16,500 |
| 2021-08-17 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 5,500 | $100.09 | $550,477 | 4,856 |
| 2021-08-17 | Chapman Rowan E | — |
Exercise / conversion
M
|
Common Stock | 5,500 | $32.15 | $176,825 | 10,356 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 9,375 | $0.00 | $0 | 28,125 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 4,570 | $0.00 | $0 | 23,320 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 7,617 | $0.00 | $0 | 38,867 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,242 | $0.00 | $0 | 44,909 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 5,285 | $0.00 | $0 | 26,652 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 25 | $0.00 | $0 | 25 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 24,062 | $101.82 | $2,450,089 | 74,961 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 9,294 | $101.24 | $940,952 | 99,023 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 9,375 | $25.46 | $238,688 | 108,317 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 4,570 | $25.46 | $116,352 | 98,942 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 7,617 | $13.01 | $99,097 | 91,130 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,242 | $20.27 | $65,715 | 94,372 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 5,285 | $9.29 | $49,098 | 80,271 |
| 2021-08-12 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 25 | $10.73 | $268 | 74,986 |
| 2021-08-11 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 1,281 | $0.00 | $0 | 62,039 |
| 2021-08-11 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 1,281 | $13.01 | $16,666 | 26,498 |
| 2021-07-23 | BOTHA ROELOF | — |
Equity grant / award
A · derivative
|
Stock Option (right to buy) | 252 | $74.17 | $18,691 | 252 |
| 2021-07-22 | HEALY JAMES | Dir |
Open-market buy
P
|
Common Stock | 2,400 | $113.00 | $271,200 | 2,400 |
| 2021-07-19 | Chapman Rowan E | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 3,000 | $0.00 | $0 | 2,712 |
| 2021-07-19 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 232 | $111.83 | $25,945 | 4,856 |
| 2021-07-19 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 1,468 | $108.47 | $159,231 | 5,088 |
| 2021-07-19 | Chapman Rowan E | — |
Open-market sell
S
|
Common Stock | 1,300 | $107.53 | $139,792 | 6,556 |
| 2021-07-19 | Chapman Rowan E | — |
Exercise / conversion
M
|
Common Stock | 3,000 | $40.93 | $122,790 | 7,856 |
| 2021-07-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Open-market sell
S
|
Common Stock | 76 | $116.20 | $8,831 | 580,126 |
| 2021-07-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 307 | $0.00 | $0 | 921 |
| 2021-07-13 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Exercise / conversion
M
|
Common Stock | 307 | — | — | 580,202 |
| 2021-07-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 168 | $122.68 | $20,611 | 455,630 |
| 2021-07-12 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 1,201 | $121.30 | $145,677 | 455,798 |
| 2021-07-12 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Common Stock | 784 | $0.00 | $0 | 18,046 |
| 2021-07-12 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Common Stock | 488 | $0.00 | $0 | 35,680 |
| 2021-07-12 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Common Stock | 32 | $0.00 | $0 | 40,400 |
| 2021-07-12 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Common Stock | 65 | $0.00 | $0 | 1,515 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,623 | $0.00 | $0 | 18,830 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,200 | $0.00 | $0 | 36,168 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 346 | $0.00 | $0 | 40,432 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 378 | $0.00 | $0 | 1,580 |
| 2021-07-09 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 5,547 | $121.00 | $671,187 | 455,630 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 2,623 | $9.29 | $24,368 | 461,177 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 2,200 | $10.41 | $22,902 | 458,554 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 346 | $9.59 | $3,318 | 456,354 |
| 2021-07-09 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 378 | $5.40 | $2,039 | 456,008 |
| 2021-07-08 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 2,032 | $113.34 | $230,302 | 25,217 |
| 2021-07-07 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 4,633 | $117.98 | $546,601 | 74,961 |
| 2021-07-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,984 | $0.00 | $0 | 23,907 |
| 2021-07-07 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 3,984 | — | — | 27,249 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 27 | $0.00 | $0 | 50 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 4,922 | $0.00 | $0 | 27,890 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 8,203 | $0.00 | $0 | 46,484 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,370 | $0.00 | $0 | 48,151 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 2,404 | $0.00 | $0 | 31,937 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 17 | $118.59 | $2,016 | 79,594 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 3,126 | $117.24 | $366,481 | 79,611 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 2,835 | $116.59 | $330,533 | 82,737 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 708 | $118.37 | $83,808 | 85,572 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 13,543 | $117.13 | $1,586,264 | 86,280 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 6,045 | $116.43 | $703,834 | 99,823 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 27 | $10.73 | $290 | 105,868 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 4,922 | $25.46 | $125,314 | 105,841 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 8,203 | $13.01 | $106,721 | 98,549 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 2,370 | $20.27 | $48,040 | 100,919 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 2,404 | $9.29 | $22,333 | 87,976 |
| 2021-07-06 | Chapman Steven Leonard | CEO AND PRESIDENT |
Open-market sell
S
|
Common Stock | 1,558 | $118.59 | $184,763 | 85,572 |
| 2021-07-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 9,375 | $0.00 | $0 | 9,375 |
| 2021-07-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 3,125 | $0.00 | $0 | 18,750 |
| 2021-07-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 9,375 | — | — | 87,130 |
| 2021-07-02 | Chapman Steven Leonard | CEO AND PRESIDENT |
Exercise / conversion
M
|
Common Stock | 3,125 | — | — | 77,755 |
| 2021-07-01 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Equity grant / award
G
|
Common Stock | 600 | $0.00 | $0 | 53,863 |
| 2021-06-28 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Open-market sell
S
|
Common Stock | 1,381 | $117.57 | $162,366 | 23,265 |
| 2021-06-28 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 201 | $117.57 | $23,632 | 455,630 |
| 2021-06-27 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 2,749 | $0.00 | $0 | 30,244 |
| 2021-06-27 | Schueren Robert Alan | CHIEF OPERATING OFFICER |
Exercise / conversion
M
|
Common Stock | 2,749 | — | — | 24,646 |
| 2021-06-27 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 446 | $0.00 | $0 | 4,917 |
| 2021-06-27 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 446 | — | — | 455,831 |
| 2021-06-25 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 700 | $0.00 | $0 | 21,453 |
| 2021-06-25 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 52 | $0.00 | $0 | 40,778 |
| 2021-06-25 | Sheena Jonathan | — |
Exercise / conversion
M · derivative
|
Stock Option (right to buy) | 87 | $0.00 | $0 | 1,958 |
| 2021-06-25 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 700 | $121.59 | $85,111 | 455,385 |
| 2021-06-25 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 700 | $9.29 | $6,503 | 456,085 |
| 2021-06-25 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 52 | $121.63 | $6,325 | 455,385 |
| 2021-06-25 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 52 | $9.59 | $499 | 455,437 |
| 2021-06-25 | Sheena Jonathan | — |
Open-market sell
S
|
Common Stock | 87 | $121.63 | $10,582 | 455,385 |
| 2021-06-25 | Sheena Jonathan | — |
Exercise / conversion
M
|
Common Stock | 87 | $5.40 | $469 | 455,472 |
| 2021-06-23 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Open-market sell
S
|
Common Stock | 430 | $115.18 | $49,526 | 96,378 |
| 2021-06-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M · derivative
|
Restricted Stock Unit | 1,077 | $0.00 | $0 | 7,541 |
| 2021-06-22 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Exercise / conversion
M
|
Common Stock | 1,077 | — | — | 96,808 |